JP2015525743A - 抗ウイルス剤としてのトリアゾール化合物 - Google Patents
抗ウイルス剤としてのトリアゾール化合物 Download PDFInfo
- Publication number
- JP2015525743A JP2015525743A JP2015519200A JP2015519200A JP2015525743A JP 2015525743 A JP2015525743 A JP 2015525743A JP 2015519200 A JP2015519200 A JP 2015519200A JP 2015519200 A JP2015519200 A JP 2015519200A JP 2015525743 A JP2015525743 A JP 2015525743A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- triazole
- diamine
- mmol
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Triazole compounds Chemical class 0.000 title claims description 102
- 239000003443 antiviral agent Substances 0.000 title claims description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 223
- 239000000203 mixture Substances 0.000 claims abstract description 92
- 238000000034 method Methods 0.000 claims abstract description 43
- 208000015181 infectious disease Diseases 0.000 claims abstract description 24
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 230000002265 prevention Effects 0.000 claims abstract description 7
- 241000711549 Hepacivirus C Species 0.000 claims description 79
- 125000000217 alkyl group Chemical group 0.000 claims description 69
- 239000003112 inhibitor Substances 0.000 claims description 28
- 125000001188 haloalkyl group Chemical group 0.000 claims description 24
- 108010050904 Interferons Proteins 0.000 claims description 18
- 102000014150 Interferons Human genes 0.000 claims description 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 16
- 210000000987 immune system Anatomy 0.000 claims description 15
- 229940079322 interferon Drugs 0.000 claims description 15
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 11
- 230000010076 replication Effects 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims description 9
- 101800001014 Non-structural protein 5A Proteins 0.000 claims description 8
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 8
- IFGWKYPVIJCTLJ-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-chloro-n,n-dimethylbenzamide Chemical compound C1=C(Cl)C(C(=O)N(C)C)=CC=C1NC1=NNC(N)=N1 IFGWKYPVIJCTLJ-UHFFFAOYSA-N 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 6
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 6
- RDNZSBZVFSBBLL-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-cyclopropylbenzonitrile Chemical compound N1C(N)=NC(NC=2C=C(C(C#N)=CC=2)C2CC2)=N1 RDNZSBZVFSBBLL-UHFFFAOYSA-N 0.000 claims description 5
- 229940124683 HCV polymerase inhibitor Drugs 0.000 claims description 5
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 5
- XPTIKEGAKXQYAK-UHFFFAOYSA-N 1-[3-[(5-amino-1h-1,2,4-triazol-3-yl)amino]phenyl]cyclopropane-1-carbonitrile Chemical compound N1C(N)=NC(NC=2C=C(C=CC=2)C2(CC2)C#N)=N1 XPTIKEGAKXQYAK-UHFFFAOYSA-N 0.000 claims description 4
- BSYWZZZAKLWHNW-UHFFFAOYSA-N 1-[4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-chlorophenyl]-3-methylurea Chemical compound C1=C(Cl)C(NC(=O)NC)=CC=C1NC1=NNC(N)=N1 BSYWZZZAKLWHNW-UHFFFAOYSA-N 0.000 claims description 4
- VZGPAPDOHXYBCV-UHFFFAOYSA-N 2-(n-(5-amino-1h-1,2,4-triazol-3-yl)-3,5-dichloroanilino)acetonitrile Chemical compound N1C(N)=NC(N(CC#N)C=2C=C(Cl)C=C(Cl)C=2)=N1 VZGPAPDOHXYBCV-UHFFFAOYSA-N 0.000 claims description 4
- QGCRTDUGMLMKET-UHFFFAOYSA-N 2-[4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-chloro-6-(trifluoromethyl)phenyl]acetonitrile Chemical compound N1C(N)=NC(NC=2C=C(C(CC#N)=C(Cl)C=2)C(F)(F)F)=N1 QGCRTDUGMLMKET-UHFFFAOYSA-N 0.000 claims description 4
- QFZFWAHAIOZYRA-UHFFFAOYSA-N 3-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-5-chlorobenzonitrile Chemical compound N1C(N)=NC(NC=2C=C(C=C(Cl)C=2)C#N)=N1 QFZFWAHAIOZYRA-UHFFFAOYSA-N 0.000 claims description 4
- FXWWNCAGCMIKCY-UHFFFAOYSA-N 3-[(5-amino-1h-1,2,4-triazol-3-yl)amino]benzoic acid Chemical compound N1C(N)=NC(NC=2C=C(C=CC=2)C(O)=O)=N1 FXWWNCAGCMIKCY-UHFFFAOYSA-N 0.000 claims description 4
- MAPGJBSFQUHSFY-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2,6-dichloro-n-(3-methylsulfonylphenyl)benzamide Chemical compound CS(=O)(=O)C1=CC=CC(NC(=O)C=2C(=CC(NC=3N=C(N)NN=3)=CC=2Cl)Cl)=C1 MAPGJBSFQUHSFY-UHFFFAOYSA-N 0.000 claims description 4
- ZSAYDFACXLJXEX-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2,6-dichloro-n-phenylbenzamide Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(C(=O)NC=3C=CC=CC=3)=C(Cl)C=2)=N1 ZSAYDFACXLJXEX-UHFFFAOYSA-N 0.000 claims description 4
- WBYQCDGRATZQNB-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2,6-dichlorobenzonitrile Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(C#N)=C(Cl)C=2)=N1 WBYQCDGRATZQNB-UHFFFAOYSA-N 0.000 claims description 4
- JFPPDOHXDDHSBK-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-(trifluoromethylsulfonyl)benzonitrile Chemical compound N1C(N)=NC(NC=2C=C(C(C#N)=CC=2)S(=O)(=O)C(F)(F)F)=N1 JFPPDOHXDDHSBK-UHFFFAOYSA-N 0.000 claims description 4
- FHRGFTKHOFNEPQ-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-chloro-6-(trifluoromethyl)benzonitrile Chemical compound N1C(N)=NC(NC=2C=C(C(C#N)=C(Cl)C=2)C(F)(F)F)=N1 FHRGFTKHOFNEPQ-UHFFFAOYSA-N 0.000 claims description 4
- CFSPSHBIVJQKBL-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-chlorobenzonitrile Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(C#N)=CC=2)=N1 CFSPSHBIVJQKBL-UHFFFAOYSA-N 0.000 claims description 4
- AYUAKSXDZSNPAM-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-tert-butylbenzonitrile Chemical compound C1=C(C#N)C(C(C)(C)C)=CC(NC=2N=C(N)NN=2)=C1 AYUAKSXDZSNPAM-UHFFFAOYSA-N 0.000 claims description 4
- SZYWTVQHQPMHLG-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-n,n-dimethylbenzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1NC1=NNC(N)=N1 SZYWTVQHQPMHLG-UHFFFAOYSA-N 0.000 claims description 4
- PLSMUJCOFOEAAA-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-n,n-dimethylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=NNC(N)=N1 PLSMUJCOFOEAAA-UHFFFAOYSA-N 0.000 claims description 4
- JYCKHYNBSJGZPT-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-n-methylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1NC1=NNC(N)=N1 JYCKHYNBSJGZPT-UHFFFAOYSA-N 0.000 claims description 4
- DWQUNFLXOBOSEB-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]benzenesulfonamide Chemical compound N1C(N)=NC(NC=2C=CC(=CC=2)S(N)(=O)=O)=N1 DWQUNFLXOBOSEB-UHFFFAOYSA-N 0.000 claims description 4
- HEPNLFKTJOUWPV-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]benzonitrile Chemical compound N1C(N)=NC(NC=2C=CC(=CC=2)C#N)=N1 HEPNLFKTJOUWPV-UHFFFAOYSA-N 0.000 claims description 4
- 229940122604 HCV protease inhibitor Drugs 0.000 claims description 4
- 229940121759 Helicase inhibitor Drugs 0.000 claims description 4
- MSSIWLXTEVXHNA-UHFFFAOYSA-N [3-[(5-amino-1h-1,2,4-triazol-3-yl)amino]phenyl]-phenylmethanone Chemical compound N1C(N)=NC(NC=2C=C(C=CC=2)C(=O)C=2C=CC=CC=2)=N1 MSSIWLXTEVXHNA-UHFFFAOYSA-N 0.000 claims description 4
- WYUAMDLQVYMYDA-UHFFFAOYSA-N [4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2,6-dichlorophenyl]-pyrrolidin-1-ylmethanone Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(C(=O)N3CCCC3)=C(Cl)C=2)=N1 WYUAMDLQVYMYDA-UHFFFAOYSA-N 0.000 claims description 4
- JIYUTBHHBSQZTK-UHFFFAOYSA-N [4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]phenyl]-morpholin-4-ylmethanone Chemical compound N1C(N)=NC(NC=2C=CC(=CC=2)C(=O)N2CCOCC2)=N1 JIYUTBHHBSQZTK-UHFFFAOYSA-N 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 claims description 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 4
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 4
- IHIBNIFURGXYTB-UHFFFAOYSA-N methyl 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2,6-dichlorobenzoate Chemical compound C1=C(Cl)C(C(=O)OC)=C(Cl)C=C1NC1=NNC(N)=N1 IHIBNIFURGXYTB-UHFFFAOYSA-N 0.000 claims description 4
- RKGZXMYGLJETMU-UHFFFAOYSA-N n-[3-[(5-amino-1h-1,2,4-triazol-3-yl)amino]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(NC=2N=C(N)NN=2)=C1 RKGZXMYGLJETMU-UHFFFAOYSA-N 0.000 claims description 4
- 229940124530 sulfonamide Drugs 0.000 claims description 4
- HUUBMTMJIQHAEN-UHFFFAOYSA-N triazole-1,4-diamine Chemical compound NC1=CN(N)N=N1 HUUBMTMJIQHAEN-UHFFFAOYSA-N 0.000 claims description 4
- UAWSLVCAUQUOOA-UHFFFAOYSA-N 3-(4-bromo-3,5-difluorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(F)=C(Br)C(F)=C1 UAWSLVCAUQUOOA-UHFFFAOYSA-N 0.000 claims description 3
- RZUISZCEBFZZBK-UHFFFAOYSA-N 3-n-[4-bromo-3-fluoro-5-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound NC1=NNC(NC=2C=C(C(Br)=C(F)C=2)C(F)(F)F)=N1 RZUISZCEBFZZBK-UHFFFAOYSA-N 0.000 claims description 3
- 125000005907 alkyl ester group Chemical group 0.000 claims description 3
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims description 3
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 3
- 150000003456 sulfonamides Chemical class 0.000 claims description 3
- RNFIYXCAWICVJS-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=CC(Cl)=C1Cl RNFIYXCAWICVJS-UHFFFAOYSA-N 0.000 claims description 2
- IKIMBDVZHRMQNK-UHFFFAOYSA-N 3-(3,4,5-trichlorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(Cl)=C(Cl)C(Cl)=C1 IKIMBDVZHRMQNK-UHFFFAOYSA-N 0.000 claims description 2
- TZZONUDDFFQOMD-UHFFFAOYSA-N 3-(3,5-dichloro-4-ethenylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(Cl)=C(C=C)C(Cl)=C1 TZZONUDDFFQOMD-UHFFFAOYSA-N 0.000 claims description 2
- WOOUIHRRZQWOEB-UHFFFAOYSA-N 3-(3,5-dichloro-4-methylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1(N)N=C(N)NN1 WOOUIHRRZQWOEB-UHFFFAOYSA-N 0.000 claims description 2
- HWBSEJRFEOOAFX-UHFFFAOYSA-N 3-(3-chloro-4-ethynylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=C(C#C)C(Cl)=C1 HWBSEJRFEOOAFX-UHFFFAOYSA-N 0.000 claims description 2
- UGKPFZHJAIDBOM-UHFFFAOYSA-N 3-(3-chloro-4-methylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound ClC=1C=C(C=CC=1C)C1(NNC(=N1)N)N UGKPFZHJAIDBOM-UHFFFAOYSA-N 0.000 claims description 2
- SHZYWCNDWODPFR-UHFFFAOYSA-N 3-(3-chloro-4-methylsulfonylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound ClC=1C=C(C=CC=1S(=O)(=O)C)C1(NNC(=N1)N)N SHZYWCNDWODPFR-UHFFFAOYSA-N 0.000 claims description 2
- NEJMZHSIQRDKBN-UHFFFAOYSA-N 3-(3-chloro-4-phenylmethoxyphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C(C=C1Cl)=CC=C1OCC1=CC=CC=C1 NEJMZHSIQRDKBN-UHFFFAOYSA-N 0.000 claims description 2
- LTMLLBPKCDLEIA-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(F)=CC(Cl)=C1 LTMLLBPKCDLEIA-UHFFFAOYSA-N 0.000 claims description 2
- FAZNVGOLMBUJON-UHFFFAOYSA-N 3-(3-chlorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=CC(Cl)=C1 FAZNVGOLMBUJON-UHFFFAOYSA-N 0.000 claims description 2
- AEVNLVXVYQXOAB-UHFFFAOYSA-N 3-(3-propan-2-ylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound CC(C)C1=CC=CC(C2(N)N=C(N)NN2)=C1 AEVNLVXVYQXOAB-UHFFFAOYSA-N 0.000 claims description 2
- XVNNWUAYBUSTNL-UHFFFAOYSA-N 3-(4-bromo-3,5-dichlorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(Cl)=C(Br)C(Cl)=C1 XVNNWUAYBUSTNL-UHFFFAOYSA-N 0.000 claims description 2
- FVSLXZPHIXCPMD-UHFFFAOYSA-N 3-(4-bromo-3-chloro-5-fluorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(F)=C(Br)C(Cl)=C1 FVSLXZPHIXCPMD-UHFFFAOYSA-N 0.000 claims description 2
- PMZVDBXOGVSYQN-UHFFFAOYSA-N 3-(4-chloro-3-nitrophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=C(Cl)C([N+]([O-])=O)=C1 PMZVDBXOGVSYQN-UHFFFAOYSA-N 0.000 claims description 2
- CFAMDEANZMHUMJ-UHFFFAOYSA-N 3-(4-methylsulfonylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1(N)N=C(N)NN1 CFAMDEANZMHUMJ-UHFFFAOYSA-N 0.000 claims description 2
- GRMNVSLTVVQTHQ-UHFFFAOYSA-N 3-[2-fluoro-3-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=CC(C(F)(F)F)=C1F GRMNVSLTVVQTHQ-UHFFFAOYSA-N 0.000 claims description 2
- IQPLEUYGFZKKRU-UHFFFAOYSA-N 3-[2-fluoro-5-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(C(F)(F)F)=CC=C1F IQPLEUYGFZKKRU-UHFFFAOYSA-N 0.000 claims description 2
- PCNDTYDBPUKNPL-UHFFFAOYSA-N 3-[3-(2,2,2-trifluoroethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=CC(CC(F)(F)F)=C1 PCNDTYDBPUKNPL-UHFFFAOYSA-N 0.000 claims description 2
- SKZKZTUXYHOAFM-UHFFFAOYSA-N 3-[3-(trifluoromethoxy)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=CC(OC(F)(F)F)=C1 SKZKZTUXYHOAFM-UHFFFAOYSA-N 0.000 claims description 2
- RAHPUZOHJNUUQC-UHFFFAOYSA-N 3-[3-(trifluoromethylsulfonyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=CC(S(=O)(=O)C(F)(F)F)=C1 RAHPUZOHJNUUQC-UHFFFAOYSA-N 0.000 claims description 2
- ILHQWBBOYKNOGN-UHFFFAOYSA-N 3-[3-chloro-4-(2-phenylethynyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C(C=C1Cl)=CC=C1C#CC1=CC=CC=C1 ILHQWBBOYKNOGN-UHFFFAOYSA-N 0.000 claims description 2
- CUIMKOWNFSWMHQ-UHFFFAOYSA-N 3-[3-chloro-4-(2H-tetrazol-5-ylmethyl)-5-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1N=NN=C1CC1=C(C=C(C=C1C(F)(F)F)C1(NNC(=N1)N)N)Cl CUIMKOWNFSWMHQ-UHFFFAOYSA-N 0.000 claims description 2
- WRBMWLGWLSJFJL-UHFFFAOYSA-N 3-[3-chloro-4-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=C(C(F)(F)F)C(Cl)=C1 WRBMWLGWLSJFJL-UHFFFAOYSA-N 0.000 claims description 2
- AVDLUZXTUUOXRN-UHFFFAOYSA-N 3-[3-chloro-4-(trifluoromethylsulfonyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=C(S(=O)(=O)C(F)(F)F)C(Cl)=C1 AVDLUZXTUUOXRN-UHFFFAOYSA-N 0.000 claims description 2
- CYXCDMPHTSFREA-UHFFFAOYSA-N 3-[3-chloro-4-fluoro-5-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(Cl)=C(F)C(C(F)(F)F)=C1 CYXCDMPHTSFREA-UHFFFAOYSA-N 0.000 claims description 2
- FOGYZUNPDDVHGX-UHFFFAOYSA-N 3-[3-chloro-5-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(Cl)=CC(C(F)(F)F)=C1 FOGYZUNPDDVHGX-UHFFFAOYSA-N 0.000 claims description 2
- SQNQLDVTLWRZRS-UHFFFAOYSA-N 3-[3-fluoro-5-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(F)=CC(C(F)(F)F)=C1 SQNQLDVTLWRZRS-UHFFFAOYSA-N 0.000 claims description 2
- JWHKZDYWGYHTLR-UHFFFAOYSA-N 3-[4-(trifluoromethylsulfonyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 JWHKZDYWGYHTLR-UHFFFAOYSA-N 0.000 claims description 2
- HCMJXZHSKOJHAR-UHFFFAOYSA-N 3-benzyl-3-N-(3,5-dichlorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound C(C1=CC=CC=C1)C1(NNC(=N1)N)NC1=CC(=CC(=C1)Cl)Cl HCMJXZHSKOJHAR-UHFFFAOYSA-N 0.000 claims description 2
- JDPUGAQGWIRTDZ-UHFFFAOYSA-N 3-methyl-3-N-(3,4,5-trichlorophenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound CC1(NNC(=N1)N)NC1=CC(=C(C(=C1)Cl)Cl)Cl JDPUGAQGWIRTDZ-UHFFFAOYSA-N 0.000 claims description 2
- LUPDBDUDDWLFSK-UHFFFAOYSA-N 4-[(1-acetyl-5-amino-1,2,4-triazol-3-yl)amino]-2,6-dichlorobenzonitrile Chemical compound N1=C(N)N(C(=O)C)N=C1NC1=CC(Cl)=C(C#N)C(Cl)=C1 LUPDBDUDDWLFSK-UHFFFAOYSA-N 0.000 claims description 2
- NCSQBTMZLQUIHI-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2,6-difluorobenzonitrile Chemical compound NC1=NNC(NC=2C=C(F)C(C#N)=C(F)C=2)=N1 NCSQBTMZLQUIHI-UHFFFAOYSA-N 0.000 claims description 2
- WNFMHKVFCRISJM-UHFFFAOYSA-N 4-[(5-amino-1h-1,2,4-triazol-3-yl)amino]-2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound NC1=NNC(NC=2C=C(C(C#N)=C(F)C=2)C(F)(F)F)=N1 WNFMHKVFCRISJM-UHFFFAOYSA-N 0.000 claims description 2
- MIDOAJBNSQXHPR-UHFFFAOYSA-N 4-[[5-amino-1-[4-(trifluoromethyl)phenyl]sulfonyl-1,2,4-triazol-3-yl]amino]-2,6-dichlorobenzonitrile Chemical compound N=1N(S(=O)(=O)C=2C=CC(=CC=2)C(F)(F)F)C(N)=NC=1NC1=CC(Cl)=C(C#N)C(Cl)=C1 MIDOAJBNSQXHPR-UHFFFAOYSA-N 0.000 claims description 2
- NJZWLBZWGUNVFJ-UHFFFAOYSA-N BrC1=C(C=C(C=C1)NC1=NNC(=N1)N)Cl.N1=NN(C=C1N)N Chemical compound BrC1=C(C=C(C=C1)NC1=NNC(=N1)N)Cl.N1=NN(C=C1N)N NJZWLBZWGUNVFJ-UHFFFAOYSA-N 0.000 claims description 2
- ASAXZMUFMDFFEI-UHFFFAOYSA-N BrC=1C=C(C=CC=1)C1(NNC(=N1)N)N Chemical compound BrC=1C=C(C=CC=1)C1(NNC(=N1)N)N ASAXZMUFMDFFEI-UHFFFAOYSA-N 0.000 claims description 2
- YFNLZAZDTLXUQB-UHFFFAOYSA-N C(C)(C)(C)C=1C=C(C=C(C=1)C(C)(C)C)C1(NNC(=N1)N)N Chemical compound C(C)(C)(C)C=1C=C(C=C(C=1)C(C)(C)C)C1(NNC(=N1)N)N YFNLZAZDTLXUQB-UHFFFAOYSA-N 0.000 claims description 2
- KBESPQLCGJOAQX-UHFFFAOYSA-N C(C)(C)(C)C=1C=C(C=CC=1)C1(NNC(=N1)N)N Chemical compound C(C)(C)(C)C=1C=C(C=CC=1)C1(NNC(=N1)N)N KBESPQLCGJOAQX-UHFFFAOYSA-N 0.000 claims description 2
- SPKAWTBTGKUAIT-UHFFFAOYSA-N C1=C(C=CC2=CC=CC=C12)C1(NNC(=N1)N)N Chemical compound C1=C(C=CC2=CC=CC=C12)C1(NNC(=N1)N)N SPKAWTBTGKUAIT-UHFFFAOYSA-N 0.000 claims description 2
- HBIVOVFOIQNRMJ-UHFFFAOYSA-N CS(=O)(=O)C=1C=C(C=CC=1)C1(NNC(=N1)N)N Chemical compound CS(=O)(=O)C=1C=C(C=CC=1)C1(NNC(=N1)N)N HBIVOVFOIQNRMJ-UHFFFAOYSA-N 0.000 claims description 2
- BATKCRPHPSNLQT-UHFFFAOYSA-N ClC=1C=C(C=C(C=1)Cl)C1(NNC(=N1)N)N Chemical compound ClC=1C=C(C=C(C=1)Cl)C1(NNC(=N1)N)N BATKCRPHPSNLQT-UHFFFAOYSA-N 0.000 claims description 2
- WSEUKUDMFYAVRF-UHFFFAOYSA-N ClC=1C=C(C=C(C=1I)Cl)C1(NNC(=N1)N)N Chemical compound ClC=1C=C(C=C(C=1I)Cl)C1(NNC(=N1)N)N WSEUKUDMFYAVRF-UHFFFAOYSA-N 0.000 claims description 2
- JYKFIYVBVWTISA-UHFFFAOYSA-N ClC=1C=C(C=CC=1[N+](=O)[O-])C1(NNC(=N1)N)N Chemical compound ClC=1C=C(C=CC=1[N+](=O)[O-])C1(NNC(=N1)N)N JYKFIYVBVWTISA-UHFFFAOYSA-N 0.000 claims description 2
- 125000001475 halogen functional group Chemical group 0.000 claims 7
- ZUVVBOBHQTWANW-UHFFFAOYSA-N 3-(3,5-dichloro-4-morpholin-4-ylsulfonylphenyl)-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound ClC=1C=C(C=C(C=1S(=O)(=O)N1CCOCC1)Cl)C1(NNC(=N1)N)N ZUVVBOBHQTWANW-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 506
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 469
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 413
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 299
- 239000007787 solid Substances 0.000 description 289
- 239000011541 reaction mixture Substances 0.000 description 260
- 239000000047 product Substances 0.000 description 224
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 223
- 239000000243 solution Substances 0.000 description 220
- 235000019439 ethyl acetate Nutrition 0.000 description 208
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 190
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 132
- 238000006243 chemical reaction Methods 0.000 description 128
- 239000000725 suspension Substances 0.000 description 128
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 113
- 239000012044 organic layer Substances 0.000 description 98
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 74
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 70
- 239000000741 silica gel Substances 0.000 description 70
- 229910002027 silica gel Inorganic materials 0.000 description 70
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 68
- 239000000377 silicon dioxide Substances 0.000 description 65
- 239000012267 brine Substances 0.000 description 64
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 64
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 63
- 239000003921 oil Substances 0.000 description 55
- 235000019198 oils Nutrition 0.000 description 55
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 50
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 49
- 229910052938 sodium sulfate Inorganic materials 0.000 description 49
- 235000011152 sodium sulphate Nutrition 0.000 description 49
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 48
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 46
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 40
- 238000004440 column chromatography Methods 0.000 description 39
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 39
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 38
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 37
- 229910000019 calcium carbonate Inorganic materials 0.000 description 37
- 235000010216 calcium carbonate Nutrition 0.000 description 37
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 36
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 36
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 36
- 238000005481 NMR spectroscopy Methods 0.000 description 35
- 229910052786 argon Inorganic materials 0.000 description 35
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 33
- 230000002829 reductive effect Effects 0.000 description 32
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 29
- MBEGFNBBAVRKLK-UHFFFAOYSA-N sodium;iminomethylideneazanide Chemical compound [Na+].[NH-]C#N MBEGFNBBAVRKLK-UHFFFAOYSA-N 0.000 description 28
- 229920006395 saturated elastomer Polymers 0.000 description 27
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 26
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 26
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 25
- 239000007858 starting material Substances 0.000 description 23
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 22
- 239000010410 layer Substances 0.000 description 21
- 238000003756 stirring Methods 0.000 description 21
- 239000000706 filtrate Substances 0.000 description 20
- 238000004128 high performance liquid chromatography Methods 0.000 description 20
- 239000004480 active ingredient Substances 0.000 description 19
- 125000005843 halogen group Chemical group 0.000 description 19
- 229910052757 nitrogen Inorganic materials 0.000 description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 229910052742 iron Inorganic materials 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 17
- 235000019270 ammonium chloride Nutrition 0.000 description 15
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 15
- 238000009472 formulation Methods 0.000 description 15
- RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 14
- UKSZBOKPHAQOMP-SVLSSHOZSA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 UKSZBOKPHAQOMP-SVLSSHOZSA-N 0.000 description 13
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 13
- 239000012230 colorless oil Substances 0.000 description 13
- 238000012746 preparative thin layer chromatography Methods 0.000 description 13
- 238000010992 reflux Methods 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000004587 chromatography analysis Methods 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 11
- 239000000908 ammonium hydroxide Substances 0.000 description 11
- 238000002648 combination therapy Methods 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- IGHFKZXUTJLJHB-UHFFFAOYSA-N 5-n,5-n,1-tris[(4-methoxyphenyl)methyl]-1,2,4-triazole-3,5-diamine Chemical compound C1=CC(OC)=CC=C1CN(C=1N(N=C(N)N=1)CC=1C=CC(OC)=CC=1)CC1=CC=C(OC)C=C1 IGHFKZXUTJLJHB-UHFFFAOYSA-N 0.000 description 9
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 9
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 9
- 239000002552 dosage form Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- TYDAOOTZVSWTJQ-UHFFFAOYSA-N 3-n-[3-(trifluoromethylsulfonyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(C=CC=2)S(=O)(=O)C(F)(F)F)=N1 TYDAOOTZVSWTJQ-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000010926 purge Methods 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 238000003818 flash chromatography Methods 0.000 description 7
- 125000001072 heteroaryl group Chemical group 0.000 description 7
- SHCYHNLOVOJDKV-UHFFFAOYSA-N methyl n-cyano-n'-(3,5-dichlorophenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC(Cl)=CC(Cl)=C1 SHCYHNLOVOJDKV-UHFFFAOYSA-N 0.000 description 7
- 239000002777 nucleoside Substances 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 125000006413 ring segment Chemical group 0.000 description 7
- XCTPFQNAHPHGFW-UHFFFAOYSA-N 3-n-(3,5-dichloro-4-methylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1NC1=NNC(N)=N1 XCTPFQNAHPHGFW-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 125000003710 aryl alkyl group Chemical group 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 239000013058 crude material Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- 150000003833 nucleoside derivatives Chemical class 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- GZUPMLXZUXLASR-UHFFFAOYSA-N 3-n-(3-propan-2-ylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound CC(C)C1=CC=CC(NC=2N=C(N)NN=2)=C1 GZUPMLXZUXLASR-UHFFFAOYSA-N 0.000 description 5
- BSHFCWWTFQFTPC-UHFFFAOYSA-N 3-n-[3,5-dichloro-4-(3,3-dimethylbut-1-ynyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound C1=C(Cl)C(C#CC(C)(C)C)=C(Cl)C=C1NC1=NNC(N)=N1 BSHFCWWTFQFTPC-UHFFFAOYSA-N 0.000 description 5
- XWXCOZMGKPCQOY-UHFFFAOYSA-N 3-n-[3-(trifluoromethoxy)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(OC(F)(F)F)C=CC=2)=N1 XWXCOZMGKPCQOY-UHFFFAOYSA-N 0.000 description 5
- QANJCBJMZZRWAS-UHFFFAOYSA-N 3-n-[3-chloro-4-(3,3-dimethylbut-1-ynyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound C1=C(Cl)C(C#CC(C)(C)C)=CC=C1NC1=NNC(N)=N1 QANJCBJMZZRWAS-UHFFFAOYSA-N 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 5
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 229940043279 diisopropylamine Drugs 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 5
- 125000002950 monocyclic group Chemical group 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- 125000003884 phenylalkyl group Chemical group 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 229960000329 ribavirin Drugs 0.000 description 5
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- UCVGAAAMGILBOD-UHFFFAOYSA-N 2,6-dichloro-4-nitrobenzoic acid Chemical compound OC(=O)C1=C(Cl)C=C([N+]([O-])=O)C=C1Cl UCVGAAAMGILBOD-UHFFFAOYSA-N 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 4
- OOVARUNYUYFQTO-UHFFFAOYSA-N 3-n-(3-tert-butylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound CC(C)(C)C1=CC=CC(NC=2N=C(N)NN=2)=C1 OOVARUNYUYFQTO-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- GKQLYSROISKDLL-UHFFFAOYSA-N EEDQ Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- HRCHJOSZZNQKGI-UHFFFAOYSA-N [3-chloro-4-fluoro-5-(trifluoromethyl)anilino]methyl-methylsulfanylcyanamide Chemical compound CSN(C#N)CNC1=CC(Cl)=C(F)C(C(F)(F)F)=C1 HRCHJOSZZNQKGI-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 4
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 229940047124 interferons Drugs 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
- 239000012669 liquid formulation Substances 0.000 description 4
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000004055 small Interfering RNA Substances 0.000 description 4
- 238000000527 sonication Methods 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- 238000013268 sustained release Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 3
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 3
- AMBPUKIGRAUHMS-UHFFFAOYSA-N 1,3-dichloro-2-cyclopropyl-5-isothiocyanatobenzene Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1C1CC1 AMBPUKIGRAUHMS-UHFFFAOYSA-N 0.000 description 3
- FWGJQBQTEZPOCP-UHFFFAOYSA-N 1,3-dichloro-2-cyclopropyl-5-nitrobenzene Chemical compound ClC1=CC([N+](=O)[O-])=CC(Cl)=C1C1CC1 FWGJQBQTEZPOCP-UHFFFAOYSA-N 0.000 description 3
- FCDBEIIBODDDEJ-UHFFFAOYSA-N 1,3-dichloro-2-iodo-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=C(I)C(Cl)=C1 FCDBEIIBODDDEJ-UHFFFAOYSA-N 0.000 description 3
- BYHONTUZZSIZMX-UHFFFAOYSA-N 1,3-dichloro-5-isothiocyanato-2-methylbenzene Chemical compound CC1=C(Cl)C=C(N=C=S)C=C1Cl BYHONTUZZSIZMX-UHFFFAOYSA-N 0.000 description 3
- NYJNWHXQEZOISL-UHFFFAOYSA-N 1-bromo-2-chloro-4-isothiocyanatobenzene Chemical compound ClC1=CC(N=C=S)=CC=C1Br NYJNWHXQEZOISL-UHFFFAOYSA-N 0.000 description 3
- CXSZPTDVXUSHES-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-1-phenylmethoxybenzene Chemical compound ClC1=CC(N=C=S)=CC=C1OCC1=CC=CC=C1 CXSZPTDVXUSHES-UHFFFAOYSA-N 0.000 description 3
- YRPFDJKENCHBBC-UHFFFAOYSA-N 2-cyclopropyl-4-isothiocyanatobenzonitrile Chemical compound S=C=NC1=CC=C(C#N)C(C2CC2)=C1 YRPFDJKENCHBBC-UHFFFAOYSA-N 0.000 description 3
- VUGARNAHLPQMTA-UHFFFAOYSA-N 2-cyclopropyl-4-nitrobenzonitrile Chemical compound [O-][N+](=O)C1=CC=C(C#N)C(C2CC2)=C1 VUGARNAHLPQMTA-UHFFFAOYSA-N 0.000 description 3
- SBNMUKHNKXNSOL-UHFFFAOYSA-N 3,5-dichloro-4-cyclopropylaniline Chemical compound ClC1=CC(N)=CC(Cl)=C1C1CC1 SBNMUKHNKXNSOL-UHFFFAOYSA-N 0.000 description 3
- GTEUMCIATAHZFK-UHFFFAOYSA-N 3,5-dichloro-4-methylaniline Chemical compound CC1=C(Cl)C=C(N)C=C1Cl GTEUMCIATAHZFK-UHFFFAOYSA-N 0.000 description 3
- RPFUCBPCSIJVSM-UHFFFAOYSA-N 3-n-(3-chlorophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(Cl)C=CC=2)=N1 RPFUCBPCSIJVSM-UHFFFAOYSA-N 0.000 description 3
- OIEVZQHMTSQAIT-UHFFFAOYSA-N 4-amino-2-cyclopropylbenzonitrile Chemical compound NC1=CC=C(C#N)C(C2CC2)=C1 OIEVZQHMTSQAIT-UHFFFAOYSA-N 0.000 description 3
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo(3.3.1)nonane Chemical compound C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 108010047761 Interferon-alpha Proteins 0.000 description 3
- 102000006992 Interferon-alpha Human genes 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 108060004795 Methyltransferase Proteins 0.000 description 3
- 235000019502 Orange oil Nutrition 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- UMGDCJDMYOKAJW-UHFFFAOYSA-M carbamimidothioate Chemical compound NC([S-])=N UMGDCJDMYOKAJW-UHFFFAOYSA-M 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229940125844 compound 46 Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- QRJYUHSAOYHMCZ-UHFFFAOYSA-N methyl n-cyano-n'-(3,4,5-trichlorophenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC(Cl)=C(Cl)C(Cl)=C1 QRJYUHSAOYHMCZ-UHFFFAOYSA-N 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000003928 nasal cavity Anatomy 0.000 description 3
- 238000004172 nitrogen cycle Methods 0.000 description 3
- 239000010502 orange oil Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 235000010265 sodium sulphite Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 2
- KCSQKZUPISRWPI-UHFFFAOYSA-N (2,6-dichloro-4-isothiocyanatophenyl)-pyrrolidin-1-ylmethanone Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1C(=O)N1CCCC1 KCSQKZUPISRWPI-UHFFFAOYSA-N 0.000 description 2
- XLZJJNWXYWENKQ-UHFFFAOYSA-N (2,6-dichloro-4-nitrophenyl)-pyrrolidin-1-ylmethanone Chemical compound ClC1=CC([N+](=O)[O-])=CC(Cl)=C1C(=O)N1CCCC1 XLZJJNWXYWENKQ-UHFFFAOYSA-N 0.000 description 2
- MRKKUGDWODATMF-SECBINFHSA-N (2R)-2-[[5-methoxy-2-(methylamino)pyrimidin-4-yl]amino]hexan-1-ol Chemical compound CCCC[C@H](CO)Nc1nc(NC)ncc1OC MRKKUGDWODATMF-SECBINFHSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 2
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 2
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 2
- NRDBEGMTZGNVTH-UHFFFAOYSA-N (3-bromo-5-nitrophenyl)-pentafluoro-$l^{6}-sulfane Chemical compound [O-][N+](=O)C1=CC(Br)=CC(S(F)(F)(F)(F)F)=C1 NRDBEGMTZGNVTH-UHFFFAOYSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 2
- LQBWNRSTDYCCDM-UHFFFAOYSA-N (4-amino-2,6-dichlorophenyl)-pyrrolidin-1-ylmethanone Chemical compound ClC1=CC(N)=CC(Cl)=C1C(=O)N1CCCC1 LQBWNRSTDYCCDM-UHFFFAOYSA-N 0.000 description 2
- YZXUDAYEXWZYKZ-UHFFFAOYSA-N (4-isothiocyanatophenyl)-morpholin-4-ylmethanone Chemical compound C=1C=C(N=C=S)C=CC=1C(=O)N1CCOCC1 YZXUDAYEXWZYKZ-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 2
- PNJQKOWOBUEEAQ-UHFFFAOYSA-N 1,2,3-trichloro-5-isothiocyanatobenzene Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1Cl PNJQKOWOBUEEAQ-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- YGYVPAAOGQDNHD-UHFFFAOYSA-N 1,3-dichloro-2-(3,3-dimethylbut-1-ynyl)-5-isothiocyanatobenzene Chemical compound CC(C)(C)C#CC1=C(Cl)C=C(N=C=S)C=C1Cl YGYVPAAOGQDNHD-UHFFFAOYSA-N 0.000 description 2
- XIHADZMUTKVSRJ-UHFFFAOYSA-N 1,3-dichloro-2-(3,3-dimethylbut-1-ynyl)-5-nitrobenzene Chemical compound CC(C)(C)C#CC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl XIHADZMUTKVSRJ-UHFFFAOYSA-N 0.000 description 2
- WMLFPZOXXAAXNZ-UHFFFAOYSA-N 1,3-dichloro-2-iodo-5-isothiocyanatobenzene Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1I WMLFPZOXXAAXNZ-UHFFFAOYSA-N 0.000 description 2
- RUVCGWLHTVGNGI-UHFFFAOYSA-N 1,3-dichloro-2-methyl-5-nitrobenzene Chemical compound CC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl RUVCGWLHTVGNGI-UHFFFAOYSA-N 0.000 description 2
- JLEMKZDHFGCHLO-UHFFFAOYSA-N 1,3-dichloro-5-isothiocyanatobenzene Chemical compound ClC1=CC(Cl)=CC(N=C=S)=C1 JLEMKZDHFGCHLO-UHFFFAOYSA-N 0.000 description 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 2
- MYDKVLLDYRCVCA-UHFFFAOYSA-N 1,3-ditert-butyl-5-isothiocyanatobenzene Chemical compound CC(C)(C)C1=CC(N=C=S)=CC(C(C)(C)C)=C1 MYDKVLLDYRCVCA-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- WQNNQGARUULQMA-UHFFFAOYSA-N 1-(2-chloro-4-isothiocyanatophenyl)-3-methylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)C=CN1C1=CC=C(N=C=S)C=C1Cl WQNNQGARUULQMA-UHFFFAOYSA-N 0.000 description 2
- RBWPBUBYDCJLCB-UHFFFAOYSA-N 1-(2-chloro-4-nitrophenyl)-3-methylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)C=CN1C1=CC=C([N+]([O-])=O)C=C1Cl RBWPBUBYDCJLCB-UHFFFAOYSA-N 0.000 description 2
- JYUGWQBTYKKQIG-UHFFFAOYSA-N 1-(4-amino-2-chlorophenyl)-3-methylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)C=CN1C1=CC=C(N)C=C1Cl JYUGWQBTYKKQIG-UHFFFAOYSA-N 0.000 description 2
- HBKPDEWGANZHJO-UHFFFAOYSA-N 1-(4-methoxyphenyl)-n-[(4-methoxyphenyl)methyl]methanamine Chemical compound C1=CC(OC)=CC=C1CNCC1=CC=C(OC)C=C1 HBKPDEWGANZHJO-UHFFFAOYSA-N 0.000 description 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- KQAWMVTXYLDSSS-UHFFFAOYSA-N 1-[3-[[5-[bis[(4-methoxyphenyl)methyl]amino]-1-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]amino]phenyl]cyclopropane-1-carbonitrile Chemical compound C1=CC(OC)=CC=C1CN(C=1N(N=C(NC=2C=C(C=CC=2)C2(CC2)C#N)N=1)CC=1C=CC(OC)=CC=1)CC1=CC=C(OC)C=C1 KQAWMVTXYLDSSS-UHFFFAOYSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- QXOGPTXQGKQSJT-UHFFFAOYSA-N 1-amino-4-[4-(3,4-dimethylphenyl)sulfanylanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound Cc1ccc(Sc2ccc(Nc3cc(c(N)c4C(=O)c5ccccc5C(=O)c34)S(O)(=O)=O)cc2)cc1C QXOGPTXQGKQSJT-UHFFFAOYSA-N 0.000 description 2
- ZCEKZPGLMUKSTD-UHFFFAOYSA-N 1-chloro-2-fluoro-5-isothiocyanato-3-(trifluoromethyl)benzene Chemical compound FC1=C(Cl)C=C(N=C=S)C=C1C(F)(F)F ZCEKZPGLMUKSTD-UHFFFAOYSA-N 0.000 description 2
- CMMQLNMZMBJQAD-UHFFFAOYSA-N 1-chloro-3-fluoro-5-isothiocyanatobenzene Chemical compound FC1=CC(Cl)=CC(N=C=S)=C1 CMMQLNMZMBJQAD-UHFFFAOYSA-N 0.000 description 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 2
- CCZPOSSEGRVGBZ-UHFFFAOYSA-N 1-isothiocyanato-3-(trifluoromethylsulfonyl)benzene Chemical compound FC(F)(F)S(=O)(=O)C1=CC=CC(N=C=S)=C1 CCZPOSSEGRVGBZ-UHFFFAOYSA-N 0.000 description 2
- FNMHESQXCQHNJF-UHFFFAOYSA-N 1-isothiocyanato-3-methylsulfonylbenzene Chemical compound CS(=O)(=O)C1=CC=CC(N=C=S)=C1 FNMHESQXCQHNJF-UHFFFAOYSA-N 0.000 description 2
- FYXPMMTZMYEICQ-UHFFFAOYSA-N 1-isothiocyanato-4-(trifluoromethylsulfonyl)benzene Chemical compound FC(F)(F)S(=O)(=O)C1=CC=C(N=C=S)C=C1 FYXPMMTZMYEICQ-UHFFFAOYSA-N 0.000 description 2
- VSEGGIPVCHEXNW-UHFFFAOYSA-N 1-isothiocyanato-4-methylsulfonylbenzene Chemical compound CS(=O)(=O)C1=CC=C(N=C=S)C=C1 VSEGGIPVCHEXNW-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- HDWARPIGEGLYFM-UHFFFAOYSA-N 1-tert-butylsulfanyl-3-tert-butylsulfinyl-5-isothiocyanatobenzene Chemical compound CC(C)(C)SC1=CC(N=C=S)=CC(S(=O)C(C)(C)C)=C1 HDWARPIGEGLYFM-UHFFFAOYSA-N 0.000 description 2
- GAYGCQNRVDZFKQ-UHFFFAOYSA-N 1-tert-butylsulfanyl-3-tert-butylsulfinyl-5-nitrobenzene Chemical compound CC(C)(C)SC1=CC([N+]([O-])=O)=CC(S(=O)C(C)(C)C)=C1 GAYGCQNRVDZFKQ-UHFFFAOYSA-N 0.000 description 2
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- ONMLZQZJOZAILW-UHFFFAOYSA-N 2,6-dichloro-4-isothiocyanato-n-(3-methylsulfonylphenyl)benzamide Chemical compound CS(=O)(=O)C1=CC=CC(NC(=O)C=2C(=CC(=CC=2Cl)N=C=S)Cl)=C1 ONMLZQZJOZAILW-UHFFFAOYSA-N 0.000 description 2
- ROMBMSYQCIKDTR-UHFFFAOYSA-N 2,6-dichloro-4-isothiocyanato-n-phenylbenzamide Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1C(=O)NC1=CC=CC=C1 ROMBMSYQCIKDTR-UHFFFAOYSA-N 0.000 description 2
- VILHPOAJVRENRY-UHFFFAOYSA-N 2,6-dichloro-4-isothiocyanatobenzonitrile Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1C#N VILHPOAJVRENRY-UHFFFAOYSA-N 0.000 description 2
- XREZGFLWLVGYRW-UHFFFAOYSA-N 2,6-dichloro-4-nitro-n-phenylbenzamide Chemical compound ClC1=CC([N+](=O)[O-])=CC(Cl)=C1C(=O)NC1=CC=CC=C1 XREZGFLWLVGYRW-UHFFFAOYSA-N 0.000 description 2
- MADGWOCVYGHPIY-UHFFFAOYSA-N 2,6-dichloro-4-nitrobenzonitrile Chemical compound [O-][N+](=O)C1=CC(Cl)=C(C#N)C(Cl)=C1 MADGWOCVYGHPIY-UHFFFAOYSA-N 0.000 description 2
- SQPKQTBXWLZCBG-UHFFFAOYSA-N 2,6-dichloro-n-(3-methylsulfonylphenyl)-4-nitrobenzamide Chemical compound CS(=O)(=O)C1=CC=CC(NC(=O)C=2C(=CC(=CC=2Cl)[N+]([O-])=O)Cl)=C1 SQPKQTBXWLZCBG-UHFFFAOYSA-N 0.000 description 2
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 2
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 2
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 2
- PSWFBSCVDYJHGT-UHFFFAOYSA-N 2-(2-chloro-4-nitrophenyl)ethynyl-trimethylsilane Chemical compound C[Si](C)(C)C#CC1=CC=C([N+]([O-])=O)C=C1Cl PSWFBSCVDYJHGT-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- RSHRLJOMJPTAKO-UHFFFAOYSA-N 2-[2-chloro-4-isothiocyanato-6-(trifluoromethyl)phenyl]acetonitrile Chemical compound FC(F)(F)C1=CC(N=C=S)=CC(Cl)=C1CC#N RSHRLJOMJPTAKO-UHFFFAOYSA-N 0.000 description 2
- QQGQHSUXYRHEGC-UHFFFAOYSA-N 2-[2-chloro-4-nitro-6-(trifluoromethyl)phenyl]acetonitrile Chemical compound [O-][N+](=O)C1=CC(Cl)=C(CC#N)C(C(F)(F)F)=C1 QQGQHSUXYRHEGC-UHFFFAOYSA-N 0.000 description 2
- WKZBIUOZDJXUME-UHFFFAOYSA-N 2-[4-amino-2-chloro-6-(trifluoromethyl)phenyl]acetonitrile Chemical compound NC1=CC(Cl)=C(CC#N)C(C(F)(F)F)=C1 WKZBIUOZDJXUME-UHFFFAOYSA-N 0.000 description 2
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 2
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 2
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 2
- UQVJUTRQHOWKSK-UHFFFAOYSA-N 2-bromo-1,3-difluoro-5-isothiocyanatobenzene Chemical compound FC1=CC(N=C=S)=CC(F)=C1Br UQVJUTRQHOWKSK-UHFFFAOYSA-N 0.000 description 2
- FFHGNDHRMWVDBM-UHFFFAOYSA-N 2-bromo-1-chloro-3-fluoro-5-isothiocyanatobenzene Chemical compound FC1=CC(N=C=S)=CC(Cl)=C1Br FFHGNDHRMWVDBM-UHFFFAOYSA-N 0.000 description 2
- XVLKSNKXUDQTCW-UHFFFAOYSA-N 2-bromo-1-chloro-5-isothiocyanato-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC(N=C=S)=CC(Cl)=C1Br XVLKSNKXUDQTCW-UHFFFAOYSA-N 0.000 description 2
- JNIYWQVBFBFJEG-UHFFFAOYSA-N 2-bromo-1-fluoro-5-isothiocyanato-3-(trifluoromethyl)benzene Chemical compound FC1=CC(N=C=S)=CC(C(F)(F)F)=C1Br JNIYWQVBFBFJEG-UHFFFAOYSA-N 0.000 description 2
- JTMIMDZXQBBTNK-UHFFFAOYSA-N 2-bromo-3-(trifluoromethylsulfonyl)aniline Chemical compound NC1=CC=CC(S(=O)(=O)C(F)(F)F)=C1Br JTMIMDZXQBBTNK-UHFFFAOYSA-N 0.000 description 2
- FGWTWAUUNYZYCU-UHFFFAOYSA-N 2-chloro-1-(3,3-dimethylbut-1-ynyl)-4-isothiocyanatobenzene Chemical compound CC(C)(C)C#CC1=CC=C(N=C=S)C=C1Cl FGWTWAUUNYZYCU-UHFFFAOYSA-N 0.000 description 2
- VFFBRONHCYNTQC-UHFFFAOYSA-N 2-chloro-1-(3,3-dimethylbut-1-ynyl)-4-nitrobenzene Chemical compound CC(C)(C)C#CC1=CC=C([N+]([O-])=O)C=C1Cl VFFBRONHCYNTQC-UHFFFAOYSA-N 0.000 description 2
- FQXFHRSYMORXKN-UHFFFAOYSA-N 2-chloro-1-iodo-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(I)C(Cl)=C1 FQXFHRSYMORXKN-UHFFFAOYSA-N 0.000 description 2
- XVNZPERIYMVTKE-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-1-(2-phenylethynyl)benzene Chemical compound ClC1=CC(N=C=S)=CC=C1C#CC1=CC=CC=C1 XVNZPERIYMVTKE-UHFFFAOYSA-N 0.000 description 2
- SHISNXOMWZVBTC-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-1-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(N=C=S)C=C1Cl SHISNXOMWZVBTC-UHFFFAOYSA-N 0.000 description 2
- NSAWWIGNFDDBAA-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-1-(trifluoromethylsulfonyl)benzene Chemical compound FC(F)(F)S(=O)(=O)C1=CC=C(N=C=S)C=C1Cl NSAWWIGNFDDBAA-UHFFFAOYSA-N 0.000 description 2
- DBZLWFVRCYBLPW-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-1-methylsulfonylbenzene Chemical compound CS(=O)(=O)C1=CC=C(N=C=S)C=C1Cl DBZLWFVRCYBLPW-UHFFFAOYSA-N 0.000 description 2
- WBGCXIZONOKKPP-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(N=C=S)C=C1Cl WBGCXIZONOKKPP-UHFFFAOYSA-N 0.000 description 2
- KNRPFTQCQBLDHS-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-6-(trifluoromethyl)benzonitrile Chemical compound FC(F)(F)C1=CC(N=C=S)=CC(Cl)=C1C#N KNRPFTQCQBLDHS-UHFFFAOYSA-N 0.000 description 2
- WMPDNCAWIKAFJF-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(N=C=S)C=C1Cl WMPDNCAWIKAFJF-UHFFFAOYSA-N 0.000 description 2
- CAOBPKIQMNOCBO-UHFFFAOYSA-N 2-chloro-4-isothiocyanatobenzonitrile Chemical compound ClC1=CC(N=C=S)=CC=C1C#N CAOBPKIQMNOCBO-UHFFFAOYSA-N 0.000 description 2
- YDEWDHRNXKQQMC-UHFFFAOYSA-N 2-chloro-4-nitro-1-(2-phenylethynyl)benzene Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1C#CC1=CC=CC=C1 YDEWDHRNXKQQMC-UHFFFAOYSA-N 0.000 description 2
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 2
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 2
- AVOZHXIYFJIZGI-UHFFFAOYSA-N 2-tert-butyl-4-isothiocyanatobenzonitrile Chemical compound CC(C)(C)C1=CC(N=C=S)=CC=C1C#N AVOZHXIYFJIZGI-UHFFFAOYSA-N 0.000 description 2
- AFVPXZQTPSJUSJ-UHFFFAOYSA-N 2-tert-butyl-4-nitrobenzonitrile Chemical compound CC(C)(C)C1=CC([N+]([O-])=O)=CC=C1C#N AFVPXZQTPSJUSJ-UHFFFAOYSA-N 0.000 description 2
- PPWNCLVNXGCGAF-UHFFFAOYSA-N 3,3-dimethylbut-1-yne Chemical compound CC(C)(C)C#C PPWNCLVNXGCGAF-UHFFFAOYSA-N 0.000 description 2
- SQPMOZJAVQRZIX-UHFFFAOYSA-N 3,5-dibromo-1-[(4-methoxyphenyl)methyl]-1,2,4-triazole Chemical compound C1=CC(OC)=CC=C1CN1C(Br)=NC(Br)=N1 SQPMOZJAVQRZIX-UHFFFAOYSA-N 0.000 description 2
- QCPKKPGOCAOQDE-UHFFFAOYSA-N 3,5-dichloro-4-(3,3-dimethylbut-1-ynyl)aniline Chemical compound CC(C)(C)C#CC1=C(Cl)C=C(N)C=C1Cl QCPKKPGOCAOQDE-UHFFFAOYSA-N 0.000 description 2
- JKXXLWQFIUSXMD-UHFFFAOYSA-N 3,5-dichloro-4-iodoaniline Chemical compound NC1=CC(Cl)=C(I)C(Cl)=C1 JKXXLWQFIUSXMD-UHFFFAOYSA-N 0.000 description 2
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 2
- LZYNHEOVZMLXIO-UHFFFAOYSA-N 3-(trifluoromethylsulfonyl)aniline Chemical compound NC1=CC=CC(S(=O)(=O)C(F)(F)F)=C1 LZYNHEOVZMLXIO-UHFFFAOYSA-N 0.000 description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 2
- HCROKBUNMALNHZ-UHFFFAOYSA-N 3-bromo-5-(pentafluoro-$l^{6}-sulfanyl)aniline Chemical compound NC1=CC(Br)=CC(S(F)(F)(F)(F)F)=C1 HCROKBUNMALNHZ-UHFFFAOYSA-N 0.000 description 2
- QFHUQLOPIKMFBI-UHFFFAOYSA-N 3-chloro-4-(2-phenylethynyl)aniline Chemical compound ClC1=CC(N)=CC=C1C#CC1=CC=CC=C1 QFHUQLOPIKMFBI-UHFFFAOYSA-N 0.000 description 2
- WAZWFIOLSVFUSU-UHFFFAOYSA-N 3-chloro-4-(2-trimethylsilylethynyl)aniline Chemical compound C[Si](C)(C)C#CC1=CC=C(N)C=C1Cl WAZWFIOLSVFUSU-UHFFFAOYSA-N 0.000 description 2
- CBRIDNWWZXILEA-UHFFFAOYSA-N 3-chloro-4-(3,3-dimethylbut-1-ynyl)aniline Chemical compound CC(C)(C)C#CC1=CC=C(N)C=C1Cl CBRIDNWWZXILEA-UHFFFAOYSA-N 0.000 description 2
- WLVBIJYMNPQHPC-UHFFFAOYSA-N 3-chloro-4-(trifluoromethylsulfonyl)aniline Chemical compound NC1=CC=C(S(=O)(=O)C(F)(F)F)C(Cl)=C1 WLVBIJYMNPQHPC-UHFFFAOYSA-N 0.000 description 2
- RFXWDLYDFAZNLO-UHFFFAOYSA-N 3-fluoro-5-(pentafluoro-$l^{6}-sulfanyl)aniline Chemical compound NC1=CC(F)=CC(S(F)(F)(F)(F)F)=C1 RFXWDLYDFAZNLO-UHFFFAOYSA-N 0.000 description 2
- QMOBPKLDMKUOCQ-UHFFFAOYSA-N 3-n-(2,3-dichlorophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C(=C(Cl)C=CC=2)Cl)=N1 QMOBPKLDMKUOCQ-UHFFFAOYSA-N 0.000 description 2
- QDKVFYCVRGVORC-UHFFFAOYSA-N 3-n-(3,4,5-trichlorophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(Cl)=C(Cl)C=2)=N1 QDKVFYCVRGVORC-UHFFFAOYSA-N 0.000 description 2
- MLAUFOKZYBXDMN-UHFFFAOYSA-N 3-n-(3,5-dichloro-4-iodophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(I)=C(Cl)C=2)=N1 MLAUFOKZYBXDMN-UHFFFAOYSA-N 0.000 description 2
- VSESXTJZECWING-UHFFFAOYSA-N 3-n-(3,5-dichloro-4-morpholin-4-ylsulfonylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(=C(Cl)C=2)S(=O)(=O)N2CCOCC2)=N1 VSESXTJZECWING-UHFFFAOYSA-N 0.000 description 2
- KAAPUKIJYXDSJG-UHFFFAOYSA-N 3-n-(3,5-dichlorophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound NC1=NNC(NC=2C=C(Cl)C=C(Cl)C=2)=N1 KAAPUKIJYXDSJG-UHFFFAOYSA-N 0.000 description 2
- PMJONGNBLSJFNQ-UHFFFAOYSA-N 3-n-(3,5-dichlorophenyl)-3-n-methyl-1h-1,2,4-triazole-3,5-diamine Chemical compound C=1C(Cl)=CC(Cl)=CC=1N(C)C1=NNC(N)=N1 PMJONGNBLSJFNQ-UHFFFAOYSA-N 0.000 description 2
- NJECBTYCERECGE-UHFFFAOYSA-N 3-n-(3,5-ditert-butylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(NC=2N=C(N)NN=2)=C1 NJECBTYCERECGE-UHFFFAOYSA-N 0.000 description 2
- KNBIDGHRWNWBOZ-UHFFFAOYSA-N 3-n-(3-bromophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(Br)C=CC=2)=N1 KNBIDGHRWNWBOZ-UHFFFAOYSA-N 0.000 description 2
- FYJRJWINKJEOAS-UHFFFAOYSA-N 3-n-(3-chloro-4-methylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound C1=C(Cl)C(C)=CC=C1NC1=NNC(N)=N1 FYJRJWINKJEOAS-UHFFFAOYSA-N 0.000 description 2
- HCOWSDLUXYBLCQ-UHFFFAOYSA-N 3-n-(3-chloro-4-methylsulfonylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound C1=C(Cl)C(S(=O)(=O)C)=CC=C1NC1=NNC(N)=N1 HCOWSDLUXYBLCQ-UHFFFAOYSA-N 0.000 description 2
- AWDFFKZEUDZXDX-UHFFFAOYSA-N 3-n-(3-methylsulfonylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound CS(=O)(=O)C1=CC=CC(NC=2N=C(N)NN=2)=C1 AWDFFKZEUDZXDX-UHFFFAOYSA-N 0.000 description 2
- HUXAXUCRSGIWLP-UHFFFAOYSA-N 3-n-(4-bromo-3-chloro-5-fluorophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(Cl)C(Br)=C(F)C=2)=N1 HUXAXUCRSGIWLP-UHFFFAOYSA-N 0.000 description 2
- OINJFIXIOJITAQ-UHFFFAOYSA-N 3-n-(4-methylsulfonylphenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NNC(N)=N1 OINJFIXIOJITAQ-UHFFFAOYSA-N 0.000 description 2
- DFOAJQQOUCQWFB-UHFFFAOYSA-N 3-n-[2-fluoro-3-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C(=C(C=CC=2)C(F)(F)F)F)=N1 DFOAJQQOUCQWFB-UHFFFAOYSA-N 0.000 description 2
- LJBJBRFZBRAGTH-UHFFFAOYSA-N 3-n-[2-fluoro-5-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C(=CC=C(C=2)C(F)(F)F)F)=N1 LJBJBRFZBRAGTH-UHFFFAOYSA-N 0.000 description 2
- PKQFGGBCABTMSO-UHFFFAOYSA-N 3-n-[3-(2,2,2-trifluoroethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(CC(F)(F)F)C=CC=2)=N1 PKQFGGBCABTMSO-UHFFFAOYSA-N 0.000 description 2
- AUOJLRRSKZXXBM-UHFFFAOYSA-N 3-n-[3-chloro-4-fluoro-5-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(C(F)=C(Cl)C=2)C(F)(F)F)=N1 AUOJLRRSKZXXBM-UHFFFAOYSA-N 0.000 description 2
- GVFHCQNFMKIQOT-UHFFFAOYSA-N 3-n-[3-chloro-5-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(C=C(Cl)C=2)C(F)(F)F)=N1 GVFHCQNFMKIQOT-UHFFFAOYSA-N 0.000 description 2
- VUKDQAMEBKXEAA-UHFFFAOYSA-N 3-n-[3-fluoro-5-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(C=C(F)C=2)C(F)(F)F)=N1 VUKDQAMEBKXEAA-UHFFFAOYSA-N 0.000 description 2
- HAKRUFXQYKUWAT-UHFFFAOYSA-N 3-n-[4-(trifluoromethylsulfonyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=CC(=CC=2)S(=O)(=O)C(F)(F)F)=N1 HAKRUFXQYKUWAT-UHFFFAOYSA-N 0.000 description 2
- JXRMHRICDLVMMT-UHFFFAOYSA-N 3-n-[4-bromo-3-chloro-5-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(C(Br)=C(Cl)C=2)C(F)(F)F)=N1 JXRMHRICDLVMMT-UHFFFAOYSA-N 0.000 description 2
- JOBIIJVZNSJSDN-UHFFFAOYSA-N 3-n-[4-chloro-3-(trifluoromethyl)phenyl]-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C(C(Cl)=CC=2)C(F)(F)F)=N1 JOBIIJVZNSJSDN-UHFFFAOYSA-N 0.000 description 2
- UUIKSKLTHNCTCD-UHFFFAOYSA-N 3-n-benzyl-3-n-(3,5-dichlorophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(N(CC=2C=CC=CC=2)C=2C=C(Cl)C=C(Cl)C=2)=N1 UUIKSKLTHNCTCD-UHFFFAOYSA-N 0.000 description 2
- CJGROABYLWIEDL-UHFFFAOYSA-N 3-n-methyl-3-n-(3,4,5-trichlorophenyl)-1h-1,2,4-triazole-3,5-diamine Chemical compound C=1C(Cl)=C(Cl)C(Cl)=CC=1N(C)C1=NNC(N)=N1 CJGROABYLWIEDL-UHFFFAOYSA-N 0.000 description 2
- WGMFRJYNDCEQJI-UHFFFAOYSA-N 3-n-naphthalen-2-yl-1h-1,2,4-triazole-3,5-diamine Chemical compound N1C(N)=NC(NC=2C=C3C=CC=CC3=CC=2)=N1 WGMFRJYNDCEQJI-UHFFFAOYSA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- ICFSDDVMGSOOJB-UHFFFAOYSA-N 3-tert-butylsulfanyl-5-tert-butylsulfinylaniline Chemical compound CC(C)(C)SC1=CC(N)=CC(S(=O)C(C)(C)C)=C1 ICFSDDVMGSOOJB-UHFFFAOYSA-N 0.000 description 2
- IIOAWHMPQHKWLH-UHFFFAOYSA-N 4-(2,6-dichloro-4-isothiocyanatophenyl)sulfonylmorpholine Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1S(=O)(=O)N1CCOCC1 IIOAWHMPQHKWLH-UHFFFAOYSA-N 0.000 description 2
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 2
- YUDMCNXQMDVVHL-UHFFFAOYSA-N 4-[[5-[bis[(4-methoxyphenyl)methyl]amino]-1-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]amino]benzonitrile Chemical compound C1=CC(OC)=CC=C1CN(C=1N(N=C(NC=2C=CC(=CC=2)C#N)N=1)CC=1C=CC(OC)=CC=1)CC1=CC=C(OC)C=C1 YUDMCNXQMDVVHL-UHFFFAOYSA-N 0.000 description 2
- LMKQBLGLHYHQNC-UHFFFAOYSA-N 4-amino-2,6-dichloro-n-phenylbenzamide Chemical compound ClC1=CC(N)=CC(Cl)=C1C(=O)NC1=CC=CC=C1 LMKQBLGLHYHQNC-UHFFFAOYSA-N 0.000 description 2
- UHBYXDGSKJEABP-UHFFFAOYSA-N 4-amino-2,6-dichlorobenzonitrile Chemical compound NC1=CC(Cl)=C(C#N)C(Cl)=C1 UHBYXDGSKJEABP-UHFFFAOYSA-N 0.000 description 2
- ZEMBHWPFTKCCTE-UHFFFAOYSA-N 4-amino-2-(trifluoromethylsulfonyl)benzonitrile Chemical compound NC1=CC=C(C#N)C(S(=O)(=O)C(F)(F)F)=C1 ZEMBHWPFTKCCTE-UHFFFAOYSA-N 0.000 description 2
- OKIGBZMPKDJISC-UHFFFAOYSA-N 4-amino-2-tert-butylbenzonitrile Chemical compound CC(C)(C)C1=CC(N)=CC=C1C#N OKIGBZMPKDJISC-UHFFFAOYSA-N 0.000 description 2
- KMBBWKOXVAWRJA-UHFFFAOYSA-N 4-bromo-3-(trifluoromethylsulfonyl)aniline Chemical compound NC1=CC=C(Br)C(S(=O)(=O)C(F)(F)F)=C1 KMBBWKOXVAWRJA-UHFFFAOYSA-N 0.000 description 2
- VOPLRYDSRVEQDI-UHFFFAOYSA-N 4-bromo-3-chloro-5-fluoroaniline Chemical compound NC1=CC(F)=C(Br)C(Cl)=C1 VOPLRYDSRVEQDI-UHFFFAOYSA-N 0.000 description 2
- CBGQYWGLZAEFES-UHFFFAOYSA-N 4-isothiocyanato-2-(trifluoromethylsulfonyl)benzonitrile Chemical compound FC(F)(F)S(=O)(=O)C1=CC(N=C=S)=CC=C1C#N CBGQYWGLZAEFES-UHFFFAOYSA-N 0.000 description 2
- SIYMRSJLHBGQHH-UHFFFAOYSA-N 4-isothiocyanato-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(N=C=S)C=C1 SIYMRSJLHBGQHH-UHFFFAOYSA-N 0.000 description 2
- ZAIFZABYMYTEAX-UHFFFAOYSA-N 4-isothiocyanato-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(N=C=S)C=C1 ZAIFZABYMYTEAX-UHFFFAOYSA-N 0.000 description 2
- RWAPCVBNVCMXDF-UHFFFAOYSA-N 4-isothiocyanato-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(N=C=S)C=C1 RWAPCVBNVCMXDF-UHFFFAOYSA-N 0.000 description 2
- IMDUFDNFSJWYQT-UHFFFAOYSA-N 4-isothiocyanatobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(N=C=S)C=C1 IMDUFDNFSJWYQT-UHFFFAOYSA-N 0.000 description 2
- MVXVOGCTPSBUFZ-UHFFFAOYSA-N 5-bromo-1-[(4-methoxyphenyl)methyl]-3-nitro-1,2,4-triazole Chemical compound C1=CC(OC)=CC=C1CN1C(Br)=NC([N+]([O-])=O)=N1 MVXVOGCTPSBUFZ-UHFFFAOYSA-N 0.000 description 2
- HIQPNMALMFTJDQ-UHFFFAOYSA-N 5-bromo-n,n,2-tris[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-amine Chemical compound C1=CC(OC)=CC=C1CN(C=1N(N=C(Br)N=1)CC=1C=CC(OC)=CC=1)CC1=CC=C(OC)C=C1 HIQPNMALMFTJDQ-UHFFFAOYSA-N 0.000 description 2
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 2
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 2
- HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 238000006418 Brown reaction Methods 0.000 description 2
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 2
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 2
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- 229940126639 Compound 33 Drugs 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical compound C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 239000007821 HATU Substances 0.000 description 2
- 229940124257 Interferon receptor agonist Drugs 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- SAFKPMZNOWDIMA-UVTDQMKNSA-N N#C\N=C(/SC)N(C)C1=CC(Cl)=CC(Cl)=C1 Chemical compound N#C\N=C(/SC)N(C)C1=CC(Cl)=CC(Cl)=C1 SAFKPMZNOWDIMA-UVTDQMKNSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 2
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 101800001838 Serine protease/helicase NS3 Proteins 0.000 description 2
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 2
- 108091027967 Small hairpin RNA Proteins 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 2
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 2
- IOSLINNLJFQMFF-XMMPIXPASA-N [(2R)-1-[[4-[[3-[(4-fluorophenyl)methylsulfanyl]phenoxy]methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound FC1=CC=C(CSC=2C=C(OCC3=CC=C(CN4[C@H](CCC4)CO)C=C3)C=CC=2)C=C1 IOSLINNLJFQMFF-XMMPIXPASA-N 0.000 description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 2
- PDEHJIZHYQCZDX-UHFFFAOYSA-N [(4-bromo-3-chloro-5-fluoroanilino)-methylsulfanylmethyl]cyanamide Chemical compound N#CNC(SC)NC1=CC(F)=C(Br)C(Cl)=C1 PDEHJIZHYQCZDX-UHFFFAOYSA-N 0.000 description 2
- NULFEALJWOJYFB-UHFFFAOYSA-N [3,5-dichloro-4-(pyrrolidine-1-carbonyl)anilino]methyl-methylsulfanylcyanamide Chemical compound ClC1=CC(NCN(SC)C#N)=CC(Cl)=C1C(=O)N1CCCC1 NULFEALJWOJYFB-UHFFFAOYSA-N 0.000 description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 2
- GWAKYMZZMITIBB-UHFFFAOYSA-N [[4-cyano-3-(trifluoromethylsulfonyl)anilino]-methylsulfanylmethyl]cyanamide Chemical compound N#CNC(SC)NC1=CC=C(C#N)C(S(=O)(=O)C(F)(F)F)=C1 GWAKYMZZMITIBB-UHFFFAOYSA-N 0.000 description 2
- QQIRAVWVGBTHMJ-UHFFFAOYSA-N [dimethyl-(trimethylsilylamino)silyl]methane;lithium Chemical compound [Li].C[Si](C)(C)N[Si](C)(C)C QQIRAVWVGBTHMJ-UHFFFAOYSA-N 0.000 description 2
- YQNQNVDNTFHQSW-UHFFFAOYSA-N acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester Chemical compound CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N+]([O-])=O)S1 YQNQNVDNTFHQSW-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- LHHCSNFAOIFYRV-DOVBMPENSA-N boceprevir Chemical compound O=C([C@@H]1[C@@H]2[C@@H](C2(C)C)CN1C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C)NC(C(=O)C(N)=O)CC1CCC1 LHHCSNFAOIFYRV-DOVBMPENSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940126543 compound 14 Drugs 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940125810 compound 20 Drugs 0.000 description 2
- 229940126086 compound 21 Drugs 0.000 description 2
- 229940126208 compound 22 Drugs 0.000 description 2
- 229940125833 compound 23 Drugs 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 229940125846 compound 25 Drugs 0.000 description 2
- 229940125851 compound 27 Drugs 0.000 description 2
- 229940127204 compound 29 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125877 compound 31 Drugs 0.000 description 2
- 229940125878 compound 36 Drugs 0.000 description 2
- 229940125807 compound 37 Drugs 0.000 description 2
- 229940127573 compound 38 Drugs 0.000 description 2
- 229940126540 compound 41 Drugs 0.000 description 2
- 229940127271 compound 49 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 229940126545 compound 53 Drugs 0.000 description 2
- 229940127113 compound 57 Drugs 0.000 description 2
- 229940125900 compound 59 Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- ZVTDLPBHTSMEJZ-JSZLBQEHSA-N danoprevir Chemical compound O=C([C@@]12C[C@H]1\C=C/CCCCC[C@@H](C(N1C[C@@H](C[C@H]1C(=O)N2)OC(=O)N1CC2=C(F)C=CC=C2C1)=O)NC(=O)OC(C)(C)C)NS(=O)(=O)C1CC1 ZVTDLPBHTSMEJZ-JSZLBQEHSA-N 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 2
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 150000002085 enols Chemical group 0.000 description 2
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 2
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical class CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
- 125000004404 heteroalkyl group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- ZMPXGSYLKFAGOV-UHFFFAOYSA-N hydron;3-methylsulfonylaniline;chloride Chemical compound Cl.CS(=O)(=O)C1=CC=CC(N)=C1 ZMPXGSYLKFAGOV-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 108010010648 interferon alfacon-1 Proteins 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 2
- WEKNOJQJZAWYSJ-UHFFFAOYSA-N methyl 2,6-dichloro-4-[[(cyanoamino)-methylsulfanylmethyl]amino]benzoate Chemical compound COC(=O)C1=C(Cl)C=C(NC(NC#N)SC)C=C1Cl WEKNOJQJZAWYSJ-UHFFFAOYSA-N 0.000 description 2
- PUTBFBRBGSNTCA-UHFFFAOYSA-N methyl 2,6-dichloro-4-isothiocyanatobenzoate Chemical compound COC(=O)C1=C(Cl)C=C(N=C=S)C=C1Cl PUTBFBRBGSNTCA-UHFFFAOYSA-N 0.000 description 2
- RJTPZMQVXLMSTA-UHFFFAOYSA-N methyl 3-[(5-amino-1h-1,2,4-triazol-3-yl)amino]benzoate Chemical compound COC(=O)C1=CC=CC(NC=2N=C(N)NN=2)=C1 RJTPZMQVXLMSTA-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- RVHKBIQFMDGXJL-UHFFFAOYSA-N methyl n'-(3-chlorophenyl)-n-cyanocarbamimidothioate Chemical compound N#CN=C(SC)NC1=CC=CC(Cl)=C1 RVHKBIQFMDGXJL-UHFFFAOYSA-N 0.000 description 2
- MTSCNZVEMYOACN-UHFFFAOYSA-N methyl n'-(3-tert-butylphenyl)-n-cyanocarbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=CC(C(C)(C)C)=C1 MTSCNZVEMYOACN-UHFFFAOYSA-N 0.000 description 2
- PSQQIFJCPUTTJJ-UHFFFAOYSA-N methyl n-cyano-n'-(3,5-dichloro-4-cyanophenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC(Cl)=C(C#N)C(Cl)=C1 PSQQIFJCPUTTJJ-UHFFFAOYSA-N 0.000 description 2
- HBMLCYGEWLUTLH-UHFFFAOYSA-N methyl n-cyano-n'-(3,5-dichloro-4-cyclopropylphenyl)carbamimidothioate Chemical compound ClC1=CC(NC(/SC)=N/C#N)=CC(Cl)=C1C1CC1 HBMLCYGEWLUTLH-UHFFFAOYSA-N 0.000 description 2
- BIYKXZVHHIPVOD-UHFFFAOYSA-N methyl n-cyano-n'-(3,5-dichloro-4-iodophenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC(Cl)=C(I)C(Cl)=C1 BIYKXZVHHIPVOD-UHFFFAOYSA-N 0.000 description 2
- JEUPQAJPLIXXIP-UHFFFAOYSA-N methyl n-cyano-n'-(3,5-dichloro-4-methylphenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC(Cl)=C(C)C(Cl)=C1 JEUPQAJPLIXXIP-UHFFFAOYSA-N 0.000 description 2
- GMRRPZPFVDUFMK-UHFFFAOYSA-N methyl n-cyano-n'-(3,5-ditert-butylphenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1 GMRRPZPFVDUFMK-UHFFFAOYSA-N 0.000 description 2
- YAHRJKIGKVJWQK-UHFFFAOYSA-N methyl n-cyano-n'-(3-methylsulfonylphenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=CC(S(C)(=O)=O)=C1 YAHRJKIGKVJWQK-UHFFFAOYSA-N 0.000 description 2
- GNISXAURCJBSAL-UHFFFAOYSA-N methyl n-cyano-n'-(4-cyano-3-cyclopropylphenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=C(C#N)C(C2CC2)=C1 GNISXAURCJBSAL-UHFFFAOYSA-N 0.000 description 2
- DKOLUPVPKJCOBP-UHFFFAOYSA-N methyl n-cyano-n'-(4-methylsulfonylphenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=C(S(C)(=O)=O)C=C1 DKOLUPVPKJCOBP-UHFFFAOYSA-N 0.000 description 2
- XRVLCQFFEVMILP-UHFFFAOYSA-N methyl n-cyano-n'-(4-sulfamoylphenyl)carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=C(S(N)(=O)=O)C=C1 XRVLCQFFEVMILP-UHFFFAOYSA-N 0.000 description 2
- HIJLYHGWLHXGOK-UHFFFAOYSA-N methyl n-cyano-n'-[3,5-dichloro-4-(3,3-dimethylbut-1-ynyl)phenyl]carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC(Cl)=C(C#CC(C)(C)C)C(Cl)=C1 HIJLYHGWLHXGOK-UHFFFAOYSA-N 0.000 description 2
- PNNZZJAMNVDKDD-UHFFFAOYSA-N methyl n-cyano-n'-[3-(trifluoromethylsulfonyl)phenyl]carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=CC(S(=O)(=O)C(F)(F)F)=C1 PNNZZJAMNVDKDD-UHFFFAOYSA-N 0.000 description 2
- SZPOEHZNLCIJEG-UHFFFAOYSA-N methyl n-cyano-n'-[4-(dimethylcarbamoyl)phenyl]carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=C(C(=O)N(C)C)C=C1 SZPOEHZNLCIJEG-UHFFFAOYSA-N 0.000 description 2
- APXBBXYWVHWXMV-UHFFFAOYSA-N methyl n-cyano-n'-[4-(methylsulfamoyl)phenyl]carbamimidothioate Chemical compound CNS(=O)(=O)C1=CC=C(N\C(SC)=N\C#N)C=C1 APXBBXYWVHWXMV-UHFFFAOYSA-N 0.000 description 2
- LOYONKNDJQYFPP-UHFFFAOYSA-N methyl n-cyano-n'-[4-(morpholine-4-carbonyl)phenyl]carbamimidothioate Chemical compound C1=CC(NC(/SC)=N/C#N)=CC=C1C(=O)N1CCOCC1 LOYONKNDJQYFPP-UHFFFAOYSA-N 0.000 description 2
- BYUGLEMXAHNYFW-UHFFFAOYSA-N methyl n-cyano-n'-[4-(trifluoromethylsulfonyl)phenyl]carbamimidothioate Chemical compound N#C\N=C(/SC)NC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 BYUGLEMXAHNYFW-UHFFFAOYSA-N 0.000 description 2
- NPMOYDFIINMWMT-UHFFFAOYSA-N methyl n-cyano-n'-naphthalen-2-ylcarbamimidothioate Chemical compound C1=CC=CC2=CC(NC(/SC)=N/C#N)=CC=C21 NPMOYDFIINMWMT-UHFFFAOYSA-N 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- MQAZGOPSIOXUSE-UHFFFAOYSA-N n,n,2-tris[(4-methoxyphenyl)methyl]-5-nitro-1,2,4-triazol-3-amine Chemical compound C1=CC(OC)=CC=C1CN(C=1N(N=C(N=1)[N+]([O-])=O)CC=1C=CC(OC)=CC=1)CC1=CC=C(OC)C=C1 MQAZGOPSIOXUSE-UHFFFAOYSA-N 0.000 description 2
- UQRRCQRFQGOHAI-UHFFFAOYSA-N n-(3-aminophenyl)methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(N)=C1 UQRRCQRFQGOHAI-UHFFFAOYSA-N 0.000 description 2
- RXUBAOWOCUQCJD-UHFFFAOYSA-N n-(3-isothiocyanatophenyl)methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(N=C=S)=C1 RXUBAOWOCUQCJD-UHFFFAOYSA-N 0.000 description 2
- AMOWOCUREJPCKE-UHFFFAOYSA-N n-(3-nitrophenyl)methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC([N+]([O-])=O)=C1 AMOWOCUREJPCKE-UHFFFAOYSA-N 0.000 description 2
- BFCKVQPXJSVKHB-UHFFFAOYSA-N n-[3-chloro-4-(trifluoromethylsulfanyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(SC(F)(F)F)C(Cl)=C1 BFCKVQPXJSVKHB-UHFFFAOYSA-N 0.000 description 2
- MOZVMNGFYUPQMC-UHFFFAOYSA-N n-[3-chloro-4-(trifluoromethylsulfonyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(S(=O)(=O)C(F)(F)F)C(Cl)=C1 MOZVMNGFYUPQMC-UHFFFAOYSA-N 0.000 description 2
- PSDXVBMEKZZZJQ-UHFFFAOYSA-N n-[4-bromo-3-(trifluoromethylsulfonyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Br)C(S(=O)(=O)C(F)(F)F)=C1 PSDXVBMEKZZZJQ-UHFFFAOYSA-N 0.000 description 2
- XEEQVTJTVKPTMX-UHFFFAOYSA-N n-[4-cyano-3-(trifluoromethylsulfonyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(C#N)C(S(=O)(=O)C(F)(F)F)=C1 XEEQVTJTVKPTMX-UHFFFAOYSA-N 0.000 description 2
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 2
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 229960002480 nitazoxanide Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 2
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000003961 penetration enhancing agent Substances 0.000 description 2
- GTBOGRGJUGCJIN-UHFFFAOYSA-N pentafluoro-(3-fluoro-5-isothiocyanatophenyl)-$l^{6}-sulfane Chemical compound FC1=CC(N=C=S)=CC(S(F)(F)(F)(F)F)=C1 GTBOGRGJUGCJIN-UHFFFAOYSA-N 0.000 description 2
- QGFRRADFAIRRRC-UHFFFAOYSA-N pentafluoro-(3-fluoro-5-nitrophenyl)-$l^{6}-sulfane Chemical compound [O-][N+](=O)C1=CC(F)=CC(S(F)(F)(F)(F)F)=C1 QGFRRADFAIRRRC-UHFFFAOYSA-N 0.000 description 2
- SPDKDCMHMOQEJY-UHFFFAOYSA-N pentafluoro-(3-isothiocyanatophenyl)-$l^{6}-sulfane Chemical compound FS(F)(F)(F)(F)C1=CC=CC(N=C=S)=C1 SPDKDCMHMOQEJY-UHFFFAOYSA-N 0.000 description 2
- CMBFNCPVUPRJLO-UHFFFAOYSA-N pentafluoro-(4-isothiocyanatophenyl)-$l^{6}-sulfane Chemical compound FS(F)(F)(F)(F)C1=CC=C(N=C=S)C=C1 CMBFNCPVUPRJLO-UHFFFAOYSA-N 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 239000008024 pharmaceutical diluent Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- JBSNZYDJCAPLSC-UHFFFAOYSA-N phenyl n'-(3-bromophenyl)-n-cyanocarbamimidate Chemical compound BrC1=CC=CC(NC(OC=2C=CC=CC=2)=NC#N)=C1 JBSNZYDJCAPLSC-UHFFFAOYSA-N 0.000 description 2
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- JTZZSQYMACOLNN-VDWJNHBNSA-N simeprevir Chemical compound O=C([C@@]12C[C@H]1\C=C/CCCCN(C)C(=O)[C@H]1[C@H](C(N2)=O)C[C@H](C1)OC=1C2=CC=C(C(=C2N=C(C=1)C=1SC=C(N=1)C(C)C)C)OC)NS(=O)(=O)C1CC1 JTZZSQYMACOLNN-VDWJNHBNSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- BBAWEDCPNXPBQM-GDEBMMAJSA-N telaprevir Chemical compound N([C@H](C(=O)N[C@H](C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1)C(C)(C)C)C1CCCCC1)C(=O)C1=CN=CC=N1 BBAWEDCPNXPBQM-GDEBMMAJSA-N 0.000 description 2
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 2
- 239000012414 tert-butyl nitrite Substances 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 2
- 230000007502 viral entry Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical group CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 description 2
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DZRQMHSNVNTFAQ-IVGJVWKCSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;(2r,3s,4r,5s)-1-(6-ethoxyhexyl)-2-methylpiperidine-3,4,5-triol Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.CCOCCCCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1C DZRQMHSNVNTFAQ-IVGJVWKCSA-N 0.000 description 1
- FUADXEJBHCKVBN-UHFFFAOYSA-N (3-aminophenyl)-phenylmethanone Chemical compound NC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 FUADXEJBHCKVBN-UHFFFAOYSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- WEHVQIQNGXWTME-UHFFFAOYSA-N (4-aminophenyl)-morpholin-4-ylmethanone Chemical compound C1=CC(N)=CC=C1C(=O)N1CCOCC1 WEHVQIQNGXWTME-UHFFFAOYSA-N 0.000 description 1
- ONKCBKDTKZIWHZ-MRWFHJSOSA-N (4r)-4-[[(2r)-6-amino-2-[[(2r)-2-[[4-(aminocarbamothioylamino)benzoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-5-[[(2r)-1-amino-6-[bis[2-[[4-[2-(1h-imidazol-5-yl)ethylamino]-4-oxobutanoyl]amino]acetyl]amino]-1-oxohexan-2-yl]amino]-5-oxope Chemical compound C([C@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN(C(=O)CNC(=O)CCC(=O)NCCC=1NC=NC=1)C(=O)CNC(=O)CCC(=O)NCCC=1NC=NC=1)C(N)=O)NC(=O)C=1C=CC(NC(=S)NN)=CC=1)C1=CC=C(O)C=C1 ONKCBKDTKZIWHZ-MRWFHJSOSA-N 0.000 description 1
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 1
- VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 description 1
- YQUCBFIQSJVCOR-JOCHJYFZSA-N (7r)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}-7,8-dihydro-6h-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid Chemical compound C([C@@H](CN1C2=CC(=CC=C22)C(O)=O)N(C)CCN(C)C)OC3=CC=CC=C3C1=C2C1CCCCC1 YQUCBFIQSJVCOR-JOCHJYFZSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- VHNBUFCWKWBTIZ-UHFFFAOYSA-N 1-(3-bromophenyl)cyclopropane-1-carbonitrile Chemical compound BrC1=CC=CC(C2(CC2)C#N)=C1 VHNBUFCWKWBTIZ-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- VQFKFAKEUMHBLV-BYSUZVQFSA-N 1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)[C@H](O)CCCCCCCCCCCCCC)CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQFKFAKEUMHBLV-BYSUZVQFSA-N 0.000 description 1
- HVKCZUVMQPUWSX-UHFFFAOYSA-N 1-bromo-2,3-dichlorobenzene Chemical compound ClC1=CC=CC(Br)=C1Cl HVKCZUVMQPUWSX-UHFFFAOYSA-N 0.000 description 1
- YKSXEJZFIQAUHJ-UHFFFAOYSA-N 1-bromo-2-chloro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C(Cl)=C1 YKSXEJZFIQAUHJ-UHFFFAOYSA-N 0.000 description 1
- VPXCYIIXCVJZKZ-UHFFFAOYSA-N 1-bromo-2-fluoro-3-(trifluoromethyl)benzene Chemical compound FC1=C(Br)C=CC=C1C(F)(F)F VPXCYIIXCVJZKZ-UHFFFAOYSA-N 0.000 description 1
- CQVBJYBIGXUWPB-UHFFFAOYSA-N 1-bromo-3-(2,2,2-trifluoroethyl)benzene Chemical compound FC(F)(F)CC1=CC=CC(Br)=C1 CQVBJYBIGXUWPB-UHFFFAOYSA-N 0.000 description 1
- QRPRXRQFNNXPBA-UHFFFAOYSA-N 1-bromo-3-chloro-5-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC(Cl)=CC(Br)=C1 QRPRXRQFNNXPBA-UHFFFAOYSA-N 0.000 description 1
- DXSHRLNTFMMNIQ-UHFFFAOYSA-N 1-chloro-2-fluoro-5-nitro-3-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=C(F)C(C(F)(F)F)=C1 DXSHRLNTFMMNIQ-UHFFFAOYSA-N 0.000 description 1
- WGXCKFMVBAOIFH-UHFFFAOYSA-N 1-chloro-3-isothiocyanatobenzene Chemical compound ClC1=CC=CC(N=C=S)=C1 WGXCKFMVBAOIFH-UHFFFAOYSA-N 0.000 description 1
- ZXGZBHIDSJXKLE-UHFFFAOYSA-N 1-chloro-4-isothiocyanato-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(N=C=S)=CC=C1Cl ZXGZBHIDSJXKLE-UHFFFAOYSA-N 0.000 description 1
- LFTHNVKQIOBZNA-UHFFFAOYSA-N 1-nitro-3,5-bis(trifluoromethylsulfanyl)benzene Chemical compound [O-][N+](=O)C1=CC(SC(F)(F)F)=CC(SC(F)(F)F)=C1 LFTHNVKQIOBZNA-UHFFFAOYSA-N 0.000 description 1
- JSDYQPUPSLXYCV-UHFFFAOYSA-N 1-tert-butyl-3-isothiocyanatobenzene Chemical compound CC(C)(C)C1=CC=CC(N=C=S)=C1 JSDYQPUPSLXYCV-UHFFFAOYSA-N 0.000 description 1
- FJYHOEREBAQJLQ-UHFFFAOYSA-N 2,2,2-trinitroacetic acid Chemical compound OC(=O)C([N+]([O-])=O)([N+]([O-])=O)[N+]([O-])=O FJYHOEREBAQJLQ-UHFFFAOYSA-N 0.000 description 1
- UXNGWSFGRMZMDL-UHFFFAOYSA-N 2,6-dichloro-4-[[(cyanoamino)-methylsulfanylmethyl]amino]-n-(3-methylsulfonylphenyl)benzamide Chemical compound ClC1=CC(NC(NC#N)SC)=CC(Cl)=C1C(=O)NC1=CC=CC(S(C)(=O)=O)=C1 UXNGWSFGRMZMDL-UHFFFAOYSA-N 0.000 description 1
- ZYVCLIQDOMLFBQ-UHFFFAOYSA-N 2,6-dichloro-4-[[(cyanoamino)-methylsulfanylmethyl]amino]-n-phenylbenzamide Chemical compound ClC1=CC(NC(NC#N)SC)=CC(Cl)=C1C(=O)NC1=CC=CC=C1 ZYVCLIQDOMLFBQ-UHFFFAOYSA-N 0.000 description 1
- JXZYSNWHGBGZAI-GOSISDBHSA-N 2-[(1r)-5-cyano-8-methyl-1-propyl-4,9-dihydro-3h-pyrano[3,4-b]indol-1-yl]acetic acid Chemical compound N1C2=C(C)C=CC(C#N)=C2C2=C1[C@@](CCC)(CC(O)=O)OCC2 JXZYSNWHGBGZAI-GOSISDBHSA-N 0.000 description 1
- LPPRFSRJFKEVIK-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-isothiocyanatobenzene Chemical compound ClC1=CC(N=C=S)=CC(Cl)=C1Br LPPRFSRJFKEVIK-UHFFFAOYSA-N 0.000 description 1
- RZJOIMPUMMQKFR-UHFFFAOYSA-N 2-bromo-1-fluoro-4-(trifluoromethyl)benzene Chemical compound FC1=CC=C(C(F)(F)F)C=C1Br RZJOIMPUMMQKFR-UHFFFAOYSA-N 0.000 description 1
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
- DPHCXXYPSYMICK-UHFFFAOYSA-N 2-chloro-1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(Cl)=C1 DPHCXXYPSYMICK-UHFFFAOYSA-N 0.000 description 1
- PQLHTYDGCDDPNU-UHFFFAOYSA-N 2-chloro-4-isothiocyanato-1-methylbenzene Chemical compound CC1=CC=C(N=C=S)C=C1Cl PQLHTYDGCDDPNU-UHFFFAOYSA-N 0.000 description 1
- ZIGQFRQZYVQQDR-UHFFFAOYSA-N 2-chloro-4-nitrobenzonitrile Chemical compound [O-][N+](=O)C1=CC=C(C#N)C(Cl)=C1 ZIGQFRQZYVQQDR-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
- RTMXPNYHPHIDHX-UHFFFAOYSA-N 2-isothiocyanatonaphthalene Chemical compound C1=CC=CC2=CC(N=C=S)=CC=C21 RTMXPNYHPHIDHX-UHFFFAOYSA-N 0.000 description 1
- QIQRCPPUXQAGLN-UHFFFAOYSA-N 2-pyrrolidin-1-ylacetaldehyde Chemical compound O=CCN1CCCC1 QIQRCPPUXQAGLN-UHFFFAOYSA-N 0.000 description 1
- NLKJERRQFXNBFM-UHFFFAOYSA-N 2-tert-butyl-4-nitroaniline Chemical compound CC(C)(C)C1=CC([N+]([O-])=O)=CC=C1N NLKJERRQFXNBFM-UHFFFAOYSA-N 0.000 description 1
- MLMQPDHYNJCQAO-UHFFFAOYSA-N 3,3-dimethylbutyric acid Chemical compound CC(C)(C)CC(O)=O MLMQPDHYNJCQAO-UHFFFAOYSA-N 0.000 description 1
- XOGYQVITULCUGU-UHFFFAOYSA-N 3,4,5-trichloroaniline Chemical compound NC1=CC(Cl)=C(Cl)C(Cl)=C1 XOGYQVITULCUGU-UHFFFAOYSA-N 0.000 description 1
- FRAKFBWDPXYIQO-UHFFFAOYSA-N 3,5-dibromo-1h-1,2,4-triazole Chemical compound BrC1=NNC(Br)=N1 FRAKFBWDPXYIQO-UHFFFAOYSA-N 0.000 description 1
- WVBATNXUDSTHKT-UHFFFAOYSA-N 3,5-dichloro-4-morpholin-4-ylsulfonylaniline Chemical compound ClC1=CC(N)=CC(Cl)=C1S(=O)(=O)N1CCOCC1 WVBATNXUDSTHKT-UHFFFAOYSA-N 0.000 description 1
- AGYXIUAGBLMBGV-UHFFFAOYSA-N 3,5-dimethylpyrazole-1-carboximidamide;nitric acid Chemical compound O[N+]([O-])=O.CC=1C=C(C)N(C(N)=N)N=1 AGYXIUAGBLMBGV-UHFFFAOYSA-N 0.000 description 1
- MJKNHXCPGXUEDO-UHFFFAOYSA-N 3,5-ditert-butylaniline Chemical compound CC(C)(C)C1=CC(N)=CC(C(C)(C)C)=C1 MJKNHXCPGXUEDO-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- NUFLICUHOXHWER-UHFFFAOYSA-N 3-(pentafluoro-$l^{6}-sulfanyl)aniline Chemical compound NC1=CC=CC(S(F)(F)(F)(F)F)=C1 NUFLICUHOXHWER-UHFFFAOYSA-N 0.000 description 1
- KGVMAXKQFJGOIZ-UHFFFAOYSA-N 3-[4-bromo-3-chloro-5-(trifluoromethyl)phenyl]-1,2-dihydro-1,2,4-triazole-3,5-diamine Chemical compound N1NC(N)=NC1(N)C1=CC(Cl)=C(Br)C(C(F)(F)F)=C1 KGVMAXKQFJGOIZ-UHFFFAOYSA-N 0.000 description 1
- OHKYDQYJDVQJPC-UHFFFAOYSA-N 3-[[5-[bis[(4-methoxyphenyl)methyl]amino]-1-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]amino]-5-chlorobenzonitrile Chemical compound C1=CC(OC)=CC=C1CN(C=1N(N=C(NC=2C=C(C=C(Cl)C=2)C#N)N=1)CC=1C=CC(OC)=CC=1)CC1=CC=C(OC)C=C1 OHKYDQYJDVQJPC-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- DRKWKPSNVQVDKZ-UHFFFAOYSA-N 3-bromo-5-chlorobenzonitrile Chemical compound ClC1=CC(Br)=CC(C#N)=C1 DRKWKPSNVQVDKZ-UHFFFAOYSA-N 0.000 description 1
- DHYHYLGCQVVLOQ-UHFFFAOYSA-N 3-bromoaniline Chemical compound NC1=CC=CC(Br)=C1 DHYHYLGCQVVLOQ-UHFFFAOYSA-N 0.000 description 1
- KZAMRRANXJVDCD-UHFFFAOYSA-N 3-chloro-4-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(F)F)C(Cl)=C1 KZAMRRANXJVDCD-UHFFFAOYSA-N 0.000 description 1
- BLOPJEJSRKMVSU-UHFFFAOYSA-N 3-chloro-4-(trifluoromethylsulfanyl)aniline Chemical compound NC1=CC=C(SC(F)(F)F)C(Cl)=C1 BLOPJEJSRKMVSU-UHFFFAOYSA-N 0.000 description 1
- KAHNTLCBWGVHDY-UHFFFAOYSA-N 3-chloro-4-fluoro-5-(trifluoromethyl)aniline Chemical compound NC1=CC(Cl)=C(F)C(C(F)(F)F)=C1 KAHNTLCBWGVHDY-UHFFFAOYSA-N 0.000 description 1
- VBEZMRJLMPYKBT-UHFFFAOYSA-N 3-chloro-4-methylsulfonylaniline Chemical compound CS(=O)(=O)C1=CC=C(N)C=C1Cl VBEZMRJLMPYKBT-UHFFFAOYSA-N 0.000 description 1
- LDSIOPGMLLPSSR-UHFFFAOYSA-N 3-chloro-4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C(Cl)=C1 LDSIOPGMLLPSSR-UHFFFAOYSA-N 0.000 description 1
- WOWKZTBVWKKGJV-UHFFFAOYSA-N 3-chloro-4-phenylmethoxyaniline Chemical compound ClC1=CC(N)=CC=C1OCC1=CC=CC=C1 WOWKZTBVWKKGJV-UHFFFAOYSA-N 0.000 description 1
- LPIFAHAICWJMRR-UHFFFAOYSA-N 3-chloro-5-fluoroaniline Chemical compound NC1=CC(F)=CC(Cl)=C1 LPIFAHAICWJMRR-UHFFFAOYSA-N 0.000 description 1
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- WQKQODZOQAFYPR-UHFFFAOYSA-N 3-fluoro-5-(trifluoromethyl)aniline Chemical compound NC1=CC(F)=CC(C(F)(F)F)=C1 WQKQODZOQAFYPR-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- VPLZGVOSFFCKFC-UHFFFAOYSA-N 3-methyluracil Chemical compound CN1C(=O)C=CNC1=O VPLZGVOSFFCKFC-UHFFFAOYSA-N 0.000 description 1
- XJCVRTZCHMZPBD-UHFFFAOYSA-N 3-nitroaniline Chemical compound NC1=CC=CC([N+]([O-])=O)=C1 XJCVRTZCHMZPBD-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XCCNRBCNYGWTQX-UHFFFAOYSA-N 3-propan-2-ylaniline Chemical compound CC(C)C1=CC=CC(N)=C1 XCCNRBCNYGWTQX-UHFFFAOYSA-N 0.000 description 1
- KRGOHUVXNIJQAB-UHFFFAOYSA-N 4-(3,5-diamino-1,2-dihydro-1,2,4-triazol-3-yl)-2,6-difluorobenzonitrile Chemical compound C(#N)C1=C(C=C(C=C1F)C1(N=C(NN1)N)N)F KRGOHUVXNIJQAB-UHFFFAOYSA-N 0.000 description 1
- LVIXLYURJQKVMU-UHFFFAOYSA-N 4-(3,5-diamino-1,2-dihydro-1,2,4-triazol-3-yl)-2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound C(#N)C1=C(C=C(C=C1C(F)(F)F)C1(N=C(NN1)N)N)F LVIXLYURJQKVMU-UHFFFAOYSA-N 0.000 description 1
- GNVFCXUZQGCXPB-UHFFFAOYSA-N 4-(trifluoromethylsulfonyl)aniline Chemical compound NC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 GNVFCXUZQGCXPB-UHFFFAOYSA-N 0.000 description 1
- NYPIRLYMDJMKGW-VPCXQMTMSA-N 4-amino-1-[(2r,3r,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one Chemical compound C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(N)C=C1 NYPIRLYMDJMKGW-VPCXQMTMSA-N 0.000 description 1
- XPLHLZQAQMZVEZ-UHFFFAOYSA-N 4-amino-2,6-dichloro-n-(3-methylsulfonylphenyl)benzamide Chemical compound CS(=O)(=O)C1=CC=CC(NC(=O)C=2C(=CC(N)=CC=2Cl)Cl)=C1 XPLHLZQAQMZVEZ-UHFFFAOYSA-N 0.000 description 1
- CMDRCWDZIMDARX-UHFFFAOYSA-N 4-amino-2-chloro-6-(trifluoromethyl)benzonitrile Chemical compound NC1=CC(Cl)=C(C#N)C(C(F)(F)F)=C1 CMDRCWDZIMDARX-UHFFFAOYSA-N 0.000 description 1
- HYYZVBNRQCDKET-UHFFFAOYSA-N 4-amino-2-chloro-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(N)C=C1Cl HYYZVBNRQCDKET-UHFFFAOYSA-N 0.000 description 1
- ZFBKYGFPUCUYIF-UHFFFAOYSA-N 4-amino-2-chlorobenzonitrile Chemical compound NC1=CC=C(C#N)C(Cl)=C1 ZFBKYGFPUCUYIF-UHFFFAOYSA-N 0.000 description 1
- QEPGWLBMAAEBCP-UHFFFAOYSA-N 4-amino-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(N)C=C1 QEPGWLBMAAEBCP-UHFFFAOYSA-N 0.000 description 1
- BABGMPQXLCJMSK-UHFFFAOYSA-N 4-amino-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(N)C=C1 BABGMPQXLCJMSK-UHFFFAOYSA-N 0.000 description 1
- OISQSDKFWKJEBA-UHFFFAOYSA-N 4-amino-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(N)C=C1 OISQSDKFWKJEBA-UHFFFAOYSA-N 0.000 description 1
- XGOCKBMEZPNDPJ-UHFFFAOYSA-N 4-bromo-1-chloro-2-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC(Br)=CC=C1Cl XGOCKBMEZPNDPJ-UHFFFAOYSA-N 0.000 description 1
- DKKUSFDAHRASGO-UHFFFAOYSA-N 4-bromo-3,5-difluoroaniline Chemical compound NC1=CC(F)=C(Br)C(F)=C1 DKKUSFDAHRASGO-UHFFFAOYSA-N 0.000 description 1
- WBGPOJPMDVJESG-UHFFFAOYSA-N 4-bromo-3-chloro-5-(trifluoromethyl)aniline Chemical compound NC1=CC(Cl)=C(Br)C(C(F)(F)F)=C1 WBGPOJPMDVJESG-UHFFFAOYSA-N 0.000 description 1
- QLYHPNUFNZJXOQ-UHFFFAOYSA-N 4-bromo-3-chloroaniline Chemical compound NC1=CC=C(Br)C(Cl)=C1 QLYHPNUFNZJXOQ-UHFFFAOYSA-N 0.000 description 1
- TUSDTPYFEAOYNL-UHFFFAOYSA-N 4-bromo-3-fluoro-5-(trifluoromethyl)aniline Chemical compound NC1=CC(F)=C(Br)C(C(F)(F)F)=C1 TUSDTPYFEAOYNL-UHFFFAOYSA-N 0.000 description 1
- HQSCPPCMBMFJJN-UHFFFAOYSA-N 4-bromobenzonitrile Chemical compound BrC1=CC=C(C#N)C=C1 HQSCPPCMBMFJJN-UHFFFAOYSA-N 0.000 description 1
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 1
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 1
- GIXOPPBZUGBQBY-UHFFFAOYSA-N 4-methylbenzenesulfonic acid;naphthalene-2-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 GIXOPPBZUGBQBY-UHFFFAOYSA-N 0.000 description 1
- NMEAGYKSZYLEAS-UHFFFAOYSA-N 4-methylsulfonylaniline;hydrochloride Chemical compound Cl.CS(=O)(=O)C1=CC=C(N)C=C1 NMEAGYKSZYLEAS-UHFFFAOYSA-N 0.000 description 1
- QJMYXHKGEGNLED-UHFFFAOYSA-N 5-(2-hydroxyethylamino)-1h-pyrimidine-2,4-dione Chemical compound OCCNC1=CNC(=O)NC1=O QJMYXHKGEGNLED-UHFFFAOYSA-N 0.000 description 1
- WPMJNLCLKAKMLA-UHFFFAOYSA-N 5-(3,3-dimethylbut-1-ynyl)-3-[(4-hydroxycyclohexyl)-[(4-methylcyclohexyl)-oxomethyl]amino]-2-thiophenecarboxylic acid Chemical compound C1CC(C)CCC1C(=O)N(C1=C(SC(=C1)C#CC(C)(C)C)C(O)=O)C1CCC(O)CC1 WPMJNLCLKAKMLA-UHFFFAOYSA-N 0.000 description 1
- XBEQSQDCBSKCHJ-UHFFFAOYSA-N 5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine Chemical compound FC1=CC=CC=C1C1=NC2=CN(CC=3N=NC(=CC=3)C=3C(=CC(=CC=3)C(F)(F)F)C(F)(F)F)C=CC2=N1 XBEQSQDCBSKCHJ-UHFFFAOYSA-N 0.000 description 1
- TZYVRXZQAWPIAB-FCLHUMLKSA-N 5-amino-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4h-[1,3]thiazolo[4,5-d]pyrimidine-2,7-dione Chemical compound O=C1SC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O TZYVRXZQAWPIAB-FCLHUMLKSA-N 0.000 description 1
- XXAMCWVPBITOGA-UHFFFAOYSA-N 5-bromo-3-nitro-1h-1,2,4-triazole Chemical compound [O-][N+](=O)C1=NNC(Br)=N1 XXAMCWVPBITOGA-UHFFFAOYSA-N 0.000 description 1
- WTDWVLJJJOTABN-UHFFFAOYSA-N 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-n-methyl-1-benzofuran-3-carboxamide Chemical compound C1=C2C(C(=O)NC)=C(C=3C=CC(F)=CC=3)OC2=CC(N(CCO)S(C)(=O)=O)=C1C1CC1 WTDWVLJJJOTABN-UHFFFAOYSA-N 0.000 description 1
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 1
- AMKGKYQBASDDJB-UHFFFAOYSA-N 9$l^{2}-borabicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1[B]2 AMKGKYQBASDDJB-UHFFFAOYSA-N 0.000 description 1
- PVRFQJIRERYGTQ-DSQUMVBZSA-N 9-[(2s,4ar,6r,7r,7ar)-7-fluoro-7-methyl-2-oxo-2-propan-2-yloxy-4,4a,6,7a-tetrahydrofuro[3,2-d][1,3,2]dioxaphosphinin-6-yl]-6-ethoxypurin-2-amine Chemical compound C([C@H]1O2)O[P@@](=O)(OC(C)C)O[C@H]1[C@](F)(C)[C@@H]2N1C(N=C(N)N=C2OCC)=C2N=C1 PVRFQJIRERYGTQ-DSQUMVBZSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 101710163595 Chaperone protein DnaK Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 102000001493 Cyclophilins Human genes 0.000 description 1
- 108010068682 Cyclophilins Proteins 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- LWLJUMBEZJHXHV-UHFFFAOYSA-N Dienochlor Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C1(Cl)C1(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LWLJUMBEZJHXHV-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 101710121417 Envelope glycoprotein Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 238000005863 Friedel-Crafts acylation reaction Methods 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- CATMPQFFVNKDEY-YPMHNXCESA-N Golotimod Chemical compound C1=CC=C2C(C[C@H](NC(=O)CC[C@@H](N)C(O)=O)C(O)=O)=CNC2=C1 CATMPQFFVNKDEY-YPMHNXCESA-N 0.000 description 1
- 229940124771 HCV-NS3 protease inhibitor Drugs 0.000 description 1
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 1
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 1
- 101710113864 Heat shock protein 90 Proteins 0.000 description 1
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000000521 Immunophilins Human genes 0.000 description 1
- 108010016648 Immunophilins Proteins 0.000 description 1
- 101710200424 Inosine-5'-monophosphate dehydrogenase Proteins 0.000 description 1
- 108010078049 Interferon alpha-2 Proteins 0.000 description 1
- 102100040018 Interferon alpha-2 Human genes 0.000 description 1
- 108010086140 Interferon alpha-beta Receptor Proteins 0.000 description 1
- 102000007438 Interferon alpha-beta Receptor Human genes 0.000 description 1
- 102100026720 Interferon beta Human genes 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010079944 Interferon-alpha2b Proteins 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 108010063312 Metalloproteins Proteins 0.000 description 1
- 102000010750 Metalloproteins Human genes 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 101100180399 Mus musculus Izumo1r gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 101800000212 P1A protein Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101800000862 Protease cofactor Proteins 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- MHFMTUBUVQZIRE-WINRQGAFSA-N Sovaprevir Chemical compound C([C@H](C(=O)N1[C@@H](C[C@H](C1)OC=1C2=CC=C(C=C2N=C(C=1)C=1C=CC=CC=1)OC)C(=O)N[C@]1([C@@H](C1)C=C)C(=O)NS(=O)(=O)C1CC1)C(C)(C)C)C(=O)N1CCCCC1 MHFMTUBUVQZIRE-WINRQGAFSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- 239000012317 TBTU Substances 0.000 description 1
- QYTDEUPAUMOIOP-UHFFFAOYSA-N TEMPO Chemical group CC1(C)CCCC(C)(C)N1[O] QYTDEUPAUMOIOP-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 108010078233 Thymalfasin Proteins 0.000 description 1
- 102400000800 Thymosin alpha-1 Human genes 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 238000005644 Wolff-Kishner reduction reaction Methods 0.000 description 1
- HTJGLYIJVSDQAE-VWNXEWBOSA-N [(1s,6s,7s,8r,8ar)-1,7,8-trihydroxy-1,2,3,5,6,7,8,8a-octahydroindolizin-6-yl] butanoate Chemical compound O[C@H]1[C@H](O)[C@@H](OC(=O)CCC)CN2CC[C@H](O)[C@@H]21 HTJGLYIJVSDQAE-VWNXEWBOSA-N 0.000 description 1
- ZWELIJXAKMASLK-UGKPPGOTSA-N [(2r,3r,4r,5r)-4-acetyloxy-5-(5-amino-2-oxo-[1,3]thiazolo[4,5-d]pyrimidin-3-yl)-2-(hydroxymethyl)oxolan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1[C@H](OC(=O)C)[C@@H](CO)O[C@H]1N1C(=O)SC2=CN=C(N)N=C21 ZWELIJXAKMASLK-UGKPPGOTSA-N 0.000 description 1
- HOOMGTNENMZAFP-NYNCVSEMSA-N [(2r,3r,5s)-2-(5-amino-2-oxo-[1,3]thiazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1C[C@@H](CO)O[C@H]1N1C(=O)SC2=CN=C(N)N=C21 HOOMGTNENMZAFP-NYNCVSEMSA-N 0.000 description 1
- HQMWBFHXDMAIBL-UHFFFAOYSA-N [3-[[5-[bis[(4-methoxyphenyl)methyl]amino]-1-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]amino]phenyl]-phenylmethanone Chemical compound C1=CC(OC)=CC=C1CN(C=1N(N=C(NC=2C=C(C=CC=2)C(=O)C=2C=CC=CC=2)N=1)CC=1C=CC(OC)=CC=1)CC1=CC=C(OC)C=C1 HQMWBFHXDMAIBL-UHFFFAOYSA-N 0.000 description 1
- VTQMHFOIOCKXAR-UHFFFAOYSA-N [3-chloro-4-(3-methyl-2,4-dioxopyrimidin-1-yl)anilino]methyl-methylsulfanylcyanamide Chemical compound ClC1=CC(NCN(SC)C#N)=CC=C1N1C(=O)N(C)C(=O)C=C1 VTQMHFOIOCKXAR-UHFFFAOYSA-N 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 108010080374 albuferon Proteins 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 208000021825 aldosterone-producing adrenal cortex adenoma Diseases 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 1
- 125000005422 alkyl sulfonamido group Chemical group 0.000 description 1
- 125000005466 alkylenyl group Chemical group 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 229960002118 asunaprevir Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000003725 azepanyl group Chemical group 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 150000005347 biaryls Chemical group 0.000 description 1
- BVCRERJDOOBZOH-UHFFFAOYSA-N bicyclo[2.2.1]heptanyl Chemical group C1C[C+]2CC[C-]1C2 BVCRERJDOOBZOH-UHFFFAOYSA-N 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical group C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- AZWXAPCAJCYGIA-UHFFFAOYSA-N bis(2-methylpropyl)alumane Chemical compound CC(C)C[AlH]CC(C)C AZWXAPCAJCYGIA-UHFFFAOYSA-N 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229960000517 boceprevir Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229950003414 celgosivir Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- ZTRJLSWOQIDJIS-XMMPIXPASA-N chembl469738 Chemical compound CS(=O)(=O)NC1=CC=C2NC(C=3C(=O)[C@](C4=CC=CC=C4C=3O)(C)CCC(C)C)=NS(=O)(=O)C2=C1 ZTRJLSWOQIDJIS-XMMPIXPASA-N 0.000 description 1
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- PJZPDFUUXKKDNB-KNINVFKUSA-N ciluprevir Chemical compound N([C@@H]1C(=O)N2[C@H](C(N[C@@]3(C[C@H]3\C=C/CCCCC1)C(O)=O)=O)C[C@H](C2)OC=1C2=CC=C(C=C2N=C(C=1)C=1N=C(NC(C)C)SC=1)OC)C(=O)OC1CCCC1 PJZPDFUUXKKDNB-KNINVFKUSA-N 0.000 description 1
- 229950006631 ciluprevir Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 229940126179 compound 72 Drugs 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- JZRHODNPRNTXKO-UHFFFAOYSA-N cyclohexylhydrazine;hydrochloride Chemical compound Cl.NNC1CCCCC1 JZRHODNPRNTXKO-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- WLVKDFJTYKELLQ-UHFFFAOYSA-N cyclopropylboronic acid Chemical compound OB(O)C1CC1 WLVKDFJTYKELLQ-UHFFFAOYSA-N 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- NBRBXGKOEOGLOI-UHFFFAOYSA-N dasabuvir Chemical compound C1=C(C(C)(C)C)C(OC)=C(C=2C=C3C=CC(NS(C)(=O)=O)=CC3=CC=2)C=C1N1C=CC(=O)NC1=O NBRBXGKOEOGLOI-UHFFFAOYSA-N 0.000 description 1
- 229960001418 dasabuvir Drugs 0.000 description 1
- BMAIGAHXAJEULY-UKTHLTGXSA-N deleobuvir Chemical compound C12=CC=C(C(=O)NC3(CCC3)C=3N(C4=CC(\C=C\C(O)=O)=CC=C4N=3)C)C=C2N(C)C(C=2N=CC(Br)=CN=2)=C1C1CCCC1 BMAIGAHXAJEULY-UKTHLTGXSA-N 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 125000005959 diazepanyl group Chemical group 0.000 description 1
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- 125000005050 dihydrooxazolyl group Chemical group O1C(NC=C1)* 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- SLIKWVTWIGHFJE-UHFFFAOYSA-N diphenoxymethylidenecyanamide Chemical compound C=1C=CC=CC=1OC(=NC#N)OC1=CC=CC=C1 SLIKWVTWIGHFJE-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- BOBUBHOXRCYKLI-UHFFFAOYSA-N ditert-butyl(cyclopenta-2,4-dien-1-yl)phosphane;iron(2+);(2,3,4,5-tetraphenylcyclopenta-1,4-dien-1-yl)benzene Chemical compound [Fe+2].CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1.C1=CC=CC=C1C1=C(C=2C=CC=CC=2)[C-](C=2C=CC=CC=2)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 BOBUBHOXRCYKLI-UHFFFAOYSA-N 0.000 description 1
- SACNIGZYDTUHKB-UHFFFAOYSA-N ditert-butyl-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane Chemical group CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C(C)(C)C)C(C)(C)C SACNIGZYDTUHKB-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940056913 eftilagimod alfa Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229940073621 enbrel Drugs 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 230000026502 entry into host cell Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- LLGDPTDZOVKFDU-XUHJSTDZSA-N faldaprevir Chemical compound N([C@H](C(=O)N1[C@@H](C[C@H](C1)OC=1C2=CC=C(C(=C2N=C(C=1)C=1N=C(NC(=O)C(C)C)SC=1)Br)OC)C(=O)N[C@]1([C@@H](C1)C=C)C(O)=O)C(C)(C)C)C(=O)OC1CCCC1 LLGDPTDZOVKFDU-XUHJSTDZSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 108010049353 golotimod Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- PKWIYNIDEDLDCJ-UHFFFAOYSA-N guanazole Chemical compound NC1=NNC(N)=N1 PKWIYNIDEDLDCJ-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960004931 histamine dihydrochloride Drugs 0.000 description 1
- PPZMYIBUHIPZOS-UHFFFAOYSA-N histamine dihydrochloride Chemical compound Cl.Cl.NCCC1=CN=CN1 PPZMYIBUHIPZOS-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 102000011749 human hepatitis C immune globulin Human genes 0.000 description 1
- 108010062138 human hepatitis C immune globulin Proteins 0.000 description 1
- 229940048921 humira Drugs 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229940084039 incivek Drugs 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 229940090438 infergen Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 229940065638 intron a Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 108010046177 locteron Proteins 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- MLNFEPVRHYWFOA-UHFFFAOYSA-N methyl 3-[[amino-(3,5-dimethylpyrazol-1-yl)methylidene]carbamothioylamino]benzoate Chemical compound COC(=O)C1=CC=CC(NC(=S)NC(=N)N2C(=CC(C)=N2)C)=C1 MLNFEPVRHYWFOA-UHFFFAOYSA-N 0.000 description 1
- NQXFZEJJHPUMMF-UHFFFAOYSA-N methyl 3-isothiocyanatobenzoate Chemical compound COC(=O)C1=CC=CC(N=C=S)=C1 NQXFZEJJHPUMMF-UHFFFAOYSA-N 0.000 description 1
- KBMZQFQCPXVGJR-UHFFFAOYSA-N methyl 4-amino-2,6-dichlorobenzoate Chemical compound COC(=O)C1=C(Cl)C=C(N)C=C1Cl KBMZQFQCPXVGJR-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- RNOOUTCQVCASII-UHFFFAOYSA-N methyl n-cyano-n'-(3,5-dichloro-4-morpholin-4-ylsulfonylphenyl)carbamimidothioate Chemical compound ClC1=CC(NC(/SC)=N/C#N)=CC(Cl)=C1S(=O)(=O)N1CCOCC1 RNOOUTCQVCASII-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- LCEDQNDDFOCWGG-UHFFFAOYSA-N morpholine-4-carbaldehyde Chemical compound O=CN1CCOCC1 LCEDQNDDFOCWGG-UHFFFAOYSA-N 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- BXGTVNLGPMZLAZ-UHFFFAOYSA-N n'-ethylmethanediimine;hydrochloride Chemical compound Cl.CCN=C=N BXGTVNLGPMZLAZ-UHFFFAOYSA-N 0.000 description 1
- OKDQKPLMQBXTNH-UHFFFAOYSA-N n,n-dimethyl-2h-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 description 1
- BDOMJTQKPUTJAM-UHFFFAOYSA-N n-(4-bromo-3-chloro-5-fluorophenyl)acetamide Chemical compound CC(=O)NC1=CC(F)=C(Br)C(Cl)=C1 BDOMJTQKPUTJAM-UHFFFAOYSA-N 0.000 description 1
- XMZSTQYSBYEENY-RMKNXTFCSA-N n-[4-[(e)-2-[3-tert-butyl-5-(2,4-dioxopyrimidin-1-yl)-2-methoxyphenyl]ethenyl]phenyl]methanesulfonamide Chemical compound C1=C(N2C(NC(=O)C=C2)=O)C=C(C(C)(C)C)C(OC)=C1\C=C\C1=CC=C(NS(C)(=O)=O)C=C1 XMZSTQYSBYEENY-RMKNXTFCSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
- RICZEKWVNZFTNZ-LFGITCQGSA-N narlaprevir Chemical compound N([C@H](C(=O)N1C[C@H]2[C@H](C2(C)C)[C@H]1C(=O)N[C@@H](CCCC)C(=O)C(=O)NC1CC1)C(C)(C)C)C(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1 RICZEKWVNZFTNZ-LFGITCQGSA-N 0.000 description 1
- 229950003504 narlaprevir Drugs 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000012587 nuclear overhauser effect experiment Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000005961 oxazepanyl group Chemical group 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- UAUIUKWPKRJZJV-MDJGTQRPSA-N paritaprevir Chemical compound C1=NC(C)=CN=C1C(=O)N[C@@H]1C(=O)N2C[C@H](OC=3C4=CC=CC=C4C4=CC=CC=C4N=3)C[C@H]2C(=O)N[C@]2(C(=O)NS(=O)(=O)C3CC3)C[C@@H]2\C=C/CCCCC1 UAUIUKWPKRJZJV-MDJGTQRPSA-N 0.000 description 1
- 229960002754 paritaprevir Drugs 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940002988 pegasys Drugs 0.000 description 1
- 108010092853 peginterferon alfa-2a Proteins 0.000 description 1
- 108010092851 peginterferon alfa-2b Proteins 0.000 description 1
- 229940106366 pegintron Drugs 0.000 description 1
- FSTNQYCPXJMFMT-UHFFFAOYSA-N pentafluoro-(3-nitrophenyl)-$l^{6}-sulfane Chemical compound [O-][N+](=O)C1=CC=CC(S(F)(F)(F)(F)F)=C1 FSTNQYCPXJMFMT-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical compound O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical group [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- RYXIBQLRUHDYEE-UHFFFAOYSA-M potassium;5-(cyclohexen-1-yl)-3-[(4-methoxycyclohexyl)-(4-methylcyclohexanecarbonyl)amino]thiophene-2-carboxylate Chemical compound [K+].C1CC(OC)CCC1N(C1=C(SC(=C1)C=1CCCCC=1)C([O-])=O)C(=O)C1CCC(C)CC1 RYXIBQLRUHDYEE-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- XEABSBMNTNXEJM-UHFFFAOYSA-N propagermanium Chemical compound OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O XEABSBMNTNXEJM-UHFFFAOYSA-N 0.000 description 1
- 229950002828 propagermanium Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229940021993 prophylactic vaccine Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
- 229940116176 remicade Drugs 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229950010550 resiquimod Drugs 0.000 description 1
- BXNMTOQRYBFHNZ-UHFFFAOYSA-N resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 238000011450 sequencing therapy Methods 0.000 description 1
- DEKOYVOWOVJMPM-RLHIPHHXSA-N setrobuvir Chemical compound N1([C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(O)=C(C1=O)C=1NC2=CC=C(C=C2S(=O)(=O)N=1)NS(=O)(=O)C)CC1=CC=C(F)C=C1 DEKOYVOWOVJMPM-RLHIPHHXSA-N 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 229960002091 simeprevir Drugs 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- SSERCMQZZYTNBY-UHFFFAOYSA-M sodium;3-[(4-hydroxycyclohexyl)-(4-methylcyclohexanecarbonyl)amino]-5-phenylthiophene-2-carboxylate Chemical compound [Na+].C1CC(C)CCC1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C([O-])=O)C1CCC(O)CC1 SSERCMQZZYTNBY-UHFFFAOYSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 108010017101 telaprevir Proteins 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940021747 therapeutic vaccine Drugs 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- NZVYCXVTEHPMHE-ZSUJOUNUSA-N thymalfasin Chemical compound CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NZVYCXVTEHPMHE-ZSUJOUNUSA-N 0.000 description 1
- 229960004231 thymalfasin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003970 toll like receptor agonist Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- PBIMIGNDTBRRPI-UHFFFAOYSA-N trifluoro borate Chemical compound FOB(OF)OF PBIMIGNDTBRRPI-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- HJOAXCLZLHDZDX-UHFFFAOYSA-N tris(1,2,2-trifluoroethenyl) borate Chemical compound FC(F)=C(F)OB(OC(F)=C(F)F)OC(F)=C(F)F HJOAXCLZLHDZDX-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 108010077753 type II interferon receptor Proteins 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940086210 victrelis Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
R1は、H、ハロ、低級ハロアルキル、低級ハロアルキル低級アルキル、トリフルオロメチルスルホニル、低級アルキル、アルコキシ、ニトロ、カルボキシル、低級アルキルスルホンアミド、トリフルオロメチルスルフィニル、シクロアルキル、SF5、または−NHNH2であり;
R2は、H、ハロ、シアノ、ニトロ、トリフルオロメチルスルホニル、低級ハロアルキル、フェニルエチニル、低級アルキルスルホニル、低級アルキルアミノスルホニル、低級アルキルアミド、アミノスルホニル、スルホンアミド、ベンジルオキシ、シクロアルキル、ヘテロシクロアルキルスルホニル、アリールカルボニル、低級アルキルウレア、低級アルキルエステル、フェニルアミド、ヘテロシクロアルキルカルボニル、低級アルキルスルホニルフェニルアミド、低級アルキルシアノ、シアノ低級アルキル、またはテトラゾリル低級アルキルであり;
R3は、H、ハロ、低級アルキル、低級アルケニル、低級ハロアルキル、シアノ、低級ハロアルキルオキシ、シアノシクロアルキル、低級ハロアルキル低級アルキル、SF5、またはトリフルオロメチルスルファニルであり;あるいは
R2とR3は、一緒にアリール環系を形成し;
R4は、H、低級アルキル、シアノ低級アルキル、またはフェニル低級アルキルであり;
R5は、非存在、H、低級アルキル、またはシクロアルキルであり;
R6は、Hまたはハロであり;
R7は、非存在、H、低級アルキルカルボニル、または低級ハロアルキルフェニルスルホニルであり;
ただし、R5が非存在である場合、R7は非存在ではなく;
ただし、R7が非存在である場合、R5は非存在ではない]
またはその医薬的に許容できる塩を提供する。
[0009] 本明細書中で用いる句“a”または“an”事物は、1以上のその事物を表わす;たとえば、化合物(a compound)は1種類以上の化合物または少なくとも1種類の化合物を表わす。したがって、本明細書中で用いる用語“a”(または“an”)、“1以上”および“少なくとも1”は、本明細書中で互換性をもって使用できる。
[0015] 環系内へ描かれた(明確な頂点に連結しているのではなく)記号は、その結合が適切な環原子のいずれに結合してもよいことを示す。
[0018] 用語“約(about)”は、本明細書中で大体(approximately)、付近(in the region of)、おおよそ(roughly)、またはほぼ(around)を意味するために用いられる。用語“約”を数値範囲と合わせて用いる場合、それは記述された数値の上方および下方へ境界を拡張することによりその範囲を改変する。一般に、用語“約”は、本明細書中で、記述された値の上方および下方へ20%の分散量で数値を改変するために用いられる。
[0021] たとえば、R7が非存在ではないと定義された場合、R5は非存在でなければならず、式Iは式I”:
[0022] 本明細書中で用いる技術用語および科学用語は、別途定義しない限り、本発明が関係する技術分野の専門家が一般的に理解している意味をもつ。本明細書中で当業者に既知である種々の方法および材料に言及する。薬理学の一般原理について述べた標準的な参考文献には、Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Ed., McGraw Hill Companies Inc., New York (2001)が含まれる。本発明を実施する際には、当業者に既知の適切な材料および/または方法をいずれも使用できる。しかし、好ましい材料および方法を記載する。以下の記載および実施例において言及する材料、試薬などは、別途明記しない限り、業者から入手できる。
[0025] 本明細書中で用いる用語“エステル”は式−C(=O)ORの基を表わし、式中のRは水素または本明細書中で定義する低級アルキルである。
[0034] 本明細書中で用いる用語“スルホニル”は、−SO2−基を表わす。
[0035] 本明細書中で用いる用語“アルキルスルホニル”および“アリールスルホニル”は、式−S(=O)2Rの基を表わし、式中のRはそれぞれアルキルまたはアリールであり、アルキルおよびアリールは本明細書中に定義したものである。本明細書中で用いる用語“ヘテロアルキルスルホニル”は、式−S(=O)2Rの基を表わし、式中のRは本明細書中に定義した“ヘテロアルキル”である。
[0038] 本明細書中で用いる用語“トリフルオロメチルスルフィニル”は、式−S(=O)CF3の基を表わす。
[0040] 本明細書中で用いる用語“ニトロ”は、式−N+(=O)O−の基を表わす。
[0047] 本出願は、式Iの化合物:
R1は、H、ハロ、低級ハロアルキル、低級ハロアルキル低級アルキル、トリフルオロメチルスルホニル、低級アルキル、アルコキシ、ニトロ、カルボキシル、低級アルキルスルホンアミド、トリフルオロメチルスルフィニル、シクロアルキル、SF5、または−NHNH2であり;
R2は、H、ハロ、シアノ、ニトロ、トリフルオロメチルスルホニル、低級ハロアルキル、フェニルエチニル、低級アルキルスルホニル、低級アルキルアミノスルホニル、低級アルキルアミド、アミノスルホニル、スルホンアミド、ベンジルオキシ、シクロアルキル、ヘテロシクロアルキルスルホニル、アリールカルボニル、低級アルキルウレア、低級アルキルエステル、フェニルアミド、ヘテロシクロアルキルカルボニル、低級アルキルスルホニルフェニルアミド、低級アルキルシアノ、シアノ低級アルキル、またはテトラゾリル低級アルキルであり;
R3は、H、ハロ、低級アルキル、低級アルケニル、低級ハロアルキル、シアノ、低級ハロアルキルオキシ、シアノシクロアルキル、低級ハロアルキル低級アルキル、SF5、またはトリフルオロメチルスルファニルであり;あるいは
R2とR3は、一緒にアリール環系を形成し;
R4は、H、低級アルキル、シアノ低級アルキル、またはフェニル低級アルキルであり;
R5は、非存在、H、低級アルキル、またはシクロアルキルであり;
R6は、Hまたはハロであり;
R7は、非存在、H、低級アルキルカルボニル、または低級ハロアルキルフェニルスルホニルであり;
ただし、R5が非存在である場合、R7は非存在ではなく;
ただし、R7が非存在である場合、R5は非存在ではない]
またはその医薬的に許容できる塩を提供する。
[0049] 本出願は、R4がHである、式Iの化合物を提供する。
[0050] 本出願は、R4がHであり、かつR5がHである、式Iの化合物を提供する。
[0052] 本出願は、R6がHであり、R4がHであり、かつR5がHである、式Iの化合物を提供する。
[0054] 本出願は、R2がハロである、前記のいずれかの式Iの化合物を提供する。
[0055] 本出願は、R3がハロである、前記のいずれかの式Iの化合物を提供する。
[0057] 本出願は、R1がHである、式Iの化合物を提供する。
[0059] 本出願は、R2がHである、式Iの化合物を提供する。
[0061] 本出願は、R3がHである、式Iの化合物を提供する。
[0063] 本出願は、R7が非存在であり、かつR5がHである、式Iの化合物を提供する。
[0065] 本出願は、R7が非存在であり、かつR5がシクロアルキルである、式Iの化合物を提供する。
[0067] 本出願は、R5が非存在であり、かつR7が低級アルキルである、式Iの化合物を提供する。
[0069] 本出願は、R5が非存在であり、かつR7が低級ハロアルキルフェニルスルホニルである、式Iの化合物を提供する。
[0071] 本出願は、下記からなる群から選択される化合物を提供する:
N3−(4−ブロモ−3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−ベンゾニトリル;
N3−(3,5−ジクロロ−4−ヨード−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−ブロモ−3−クロロ−5−フルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−tert−ブチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−ニトロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−エチニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,4,5−トリクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−ベンゾニトリル;
N3−(4−クロロ−3−ニトロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−フェニルエチニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−ブロモ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−tert−ブチル−ベンゾニトリル;
N3−(4−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−ナフタレン−2−イル−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジ−tert−ブチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N−メチル−ベンゼンスルホンアミド;
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−モルホリン−4−イル−メタノン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N,N−ジメチル−ベンズアミド;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−ベンゼンスルホンアミド;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N,N−ジメチル−ベンゼンスルホンアミド;
N3−メチル−N3−(3,4,5−トリクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジクロロ−フェニル)−N3−メチル−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−ベンジル−N3−(3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
[(5−アミノ−1H−[1,2,4]トリアゾール−3−イル)−(3,5−ジクロロ−フェニル)−アミノ]−アセトニトリル;
3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−安息香酸;
N3−(3−トリフルオロメタンスルフィニル−5−トリフルオロメチルスルファニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N−[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−メタンスルホンアミド;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−トリフルオロメタンスルホニル−ベンゾニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−シクロプロピル−ベンゾニトリル;
N3−(3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−ベンジルオキシ−3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジクロロ−4−メチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン
N3−(3,5−ジクロロ−4−シクロプロピル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン
N3−(4−ブロモ−3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−ブロモ−3−クロロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−6−トリフルオロメチル−ベンゾニトリル;
N3−[3,5−ジクロロ−4−(モルホリン−4−スルホニル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N5−(4−ブロモ−3−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N5−(4−ブロモ−3,5−ジフルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−ベンゾニトリル;
3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−5−クロロ−ベンゾニトリル;
N3−(2,3−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−クロロ−3−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−トリフルオロメトキシ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(2−フルオロ−3−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(2−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−[3−(2,2,2−トリフルオロ−エチル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−イソプロピル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−フェニル−メタノン;
1−[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−シクロプロパンカルボニトリル;
N3−(3−クロロ−4−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−5−フルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
1−[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−フェニル]−3−メチル−尿素;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−安息香酸 メチルエステル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−N−フェニル−ベンズアミド;
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−フェニル]−ピロリジン−1−イル−メタノン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−N−(3−メタンスルホニル−フェニル)−ベンズアミド;
N3−(3,5−ジクロロ−4−ビニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−2H−[1,2,4]トリアゾール−3−イルアミノ)−2−フルオロ−6−トリフルオロメチル−ベンゾニトリル;
N3−(3−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−2H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジフルオロ−ベンゾニトリル;
N*3*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
1−メチル−N*5*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
シクロヘキシル−N*5*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*5*−(3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1−メチル−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(4−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−メチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−N,N−ジメチル−ベンズアミド;
N3−[3,5−ジクロロ−4−(3,3−ジメチル−ブタ−1−イニル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−[3−クロロ−4−(3,3−ジメチル−ブタ−1−イニル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(4−ブロモ−3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(3−ブロモ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(4−ブロモ−3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−6−トリフルオロメチル−フェニル]−アセトニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−ペンタフルオロ硫黄−ベンゾニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−フルオロ−6−ペンタフルオロ硫黄−ベンゾニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−ヒドラジノ−6−ペンタフルオロ硫黄−ベンゾニトリル;
4−(1−アセチル−5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−ベンゾニトリル;
4−[5−アミノ−1−(4−トリフルオロメチル−ベンゼンスルホニル)−1H−[1,2,4]トリアゾール−3−イルアミノ]−2,6−ジクロロ−ベンゾニトリル;および
N3−[3−クロロ−4−(1H−テトラゾール−5−イルメチル)−5−トリフルオロメチル−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン。
[0074] 本出願は、C型肝炎ウイルス(HCV)感染症を治療するための方法であって、その必要がある患者に療法有効量の式Iの化合物を投与することを含む方法を提供する。
[0076] 本出願は、さらに、免疫系調節剤もしくはHCVの複製を阻害する抗ウイルス剤、またはその組合わせを投与することを含む、前記のいずれかの方法を提供する。
[0078] 本出願は、さらに、免疫系調節剤もしくはHCVの複製を阻害する抗ウイルス剤、またはその組合わせを投与することを含み、抗ウイルス剤が、HCVプロテアーゼ阻害剤、HCVポリメラーゼ阻害剤、HCVヘリカーゼ阻害剤、HCV NS5A阻害剤、またはそのいずれかの組合わせからなる群から選択される、前記のいずれかの方法を提供する。
[0080] 本出願は、HCVの予防のための医薬の調製における式Iの化合物の使用を提供する。
[0082] 本出願は、本明細書に記載するいずれかの化合物、組成物または使用を提供する。
[0083] 本発明により包含される、本発明の範囲内にある化合物の代表的化合物の例を下記の表に示す。これらの例および後続の製造法は、当業者が本発明をより明確に理解し、かつ実施できるようにするために示される。それらは本発明の範囲を限定するものとみなすべきではなく、単に本発明の説明および代表例とみなすべきである。
一般的スキーム
[0086] 以下のスキームは式Iの化合物を得るための一般法を示す。
[0088] 本発明の化合物は、多様な経口投与剤形およびキャリヤー中に配合できる。経口投与は、錠剤、コーティング錠、糖衣錠、ハードおよびソフトゼラチンカプセル剤、液剤、乳剤、シロップ剤、または懸濁液剤の形態で行なうことができる。本発明の化合物は、他の投与経路のうち、連続(静脈内点滴)、局所、非経口、筋肉内、静脈内、皮下、経皮(透過増強剤を含有してもよい)、口腔、鼻腔、吸入および坐剤投与を含む他の投与経路により投与した場合にも有効である。好ましい投与様式は、一般に好都合な各日投与計画を用いる経口投与であり、それは疾患の程度および有効成分に対する患者の応答に従って調整できる。
適応症
[0106] 本出願は、C型肝炎ウイルス(HCV)感染症を予防するための方法であって、その必要がある患者に療法有効量の式Iの化合物を投与することを含む方法を提供する。
[0108] 本出願は、C型肝炎ウイルス(HCV)感染症を治療するための方法であって、その必要がある患者に療法有効量の式Iの化合物を投与することを含む方法を提供する。
[0110] 本出願は、免疫系抑制剤がインターフェロンまたは化学的に誘導体化したインターフェロンである、前記の方法を提供する。
[0112] したがって、本発明の化合物およびそれらの異性形ならびにその医薬的に許容できる塩類は、単独で、またはHCVライフサイクルに関与するウイルス性または細胞性エレメントをターゲッティングする他の化合物と併用した際に、HCV感染症を治療および予防するのに有用である。本発明に有用な化合物のクラスには、限定ではなくすべてのクラスのHCV抗ウイルス剤が含まれる。
[0121] 本出願は、C型肝炎ウイルス(HCV)感染症を治療するための方法であって、その必要がある患者に療法有効量の式Iの化合物を投与することを含む方法を提供する。
[0123] 本出願は、免疫系抑制剤がインターフェロンまたは化学的に誘導体化したインターフェロンである、前記の方法を提供する。
[0125] 一般に用いられる略号には下記のものが含まれる:アセチル(Ac)、アゾ−ビス−イソブチロニトリル(AIBN)、大気(Atm)、9−ボラビシクロ[3.3.1]ノナン(9−BBNまたはBBN)、2,2’−ビス(ジフェニルホスフィノ)−1,1’−ビナフチル(BINAP)、tert−ブトキシカルボニル(Boc)、ピロ炭酸ジ−tert−ブチルまたはboc無水物(BOC2O)、ベンジル(Bn)、ブチル(Bu)、ケミカルアブストラクツ登録番号(Chemical Abstracts Registration Number)(CASRN)、ベンジルオキシカルボニル(CBZまたはZ)、カルボニルジイミダゾール(CDI)、1,4−ジアザビシクロ[2.2.2]オクタン(DABCO)、ジエチルアミノ硫黄トリフルオリド(DAST)、ジベンジリデンアセトン(dba)、1,5−ジアザビシクロ[4.3.0]ノナ−5−エン(DBN)、1,8−ジアザビシクロ[5.4.0]ウンデカ−7−エン(DBU)、N,N’−ジシクロヘキシルカルボジイミド(DCC)、1,2−ジクロロエタン(DCE)、ジクロロメタン(DCM)、2,3−ジクロロ−5,6−ジシアノ−1,4−ベンゾキノン(DDQ)、アゾジカルボン酸ジエチル(DEAD)、アゾジカルボン酸ジ−イソ−プロピル(DIAD)、水素化ジ−イソ−ブチルアルミニウム(DIBALまたはDIBAL−H)、ジ−イソ−プロピルエチルアミン(DIPEA)、N,N−ジメチルアセトアミド(DMA)、4−N,N−ジメチルアミノピリジン(DMAP)、N,N−ジメチルホルムアミド(DMF)、ジメチルスルホキシド(DMSO)、1,1’−ビス−(ジフェニルホスフィノ)エタン(dppe)、1,1’−ビス−(ジフェニルホスフィノ)フェロセン(dppf)、1−(3−ジメチルアミノプロピル)−3−エチルカルボジイミド塩酸塩(EDCI)、2−エトキシ−1−エトキシカルボニル−1,2−ジヒドロキノリン(EEDQ)、エチル(Et)、酢酸エチル(EtOAc)、エタノール(EtOH)、2−エトキシ−2H−キノリン−1−カルボン酸エチルエステル(EEDQ)、ジエチルエーテル(Et2O)、エチルイソプロピルエーテル(EtOiPr)、O−(7−アザベンゾトリアゾール−1−イル)−N、N,N’N’−テトラメチルウロニウムヘキサフルオロホスフェート酢酸(HATU)、酢酸(HOAc)、1−N−ヒドロキシベンゾトリアゾール(HOBt)、高速液体クロマトグラフィー(HPLC)、イソ−プロパノール(IPA)、イソプロピルマグシウムクロリド(iPrMgCl)、ヘキサメチルジシラザン(HMDS)、液体クロマトグラフィー質量分析(LCMS)、リチウムヘキサメチルジシラザン(LiHMDS)、メタ−クロロペルオキシ安息香酸(m−CPBA)、メタノール(MeOH)、融点(mp)、MeSO2−(メシルまたはMs)、メチル(Me)、アセトニトリル(MeCN)、m−クロロ過安息香酸(MCPBA)、質量スペクトル(ms)、メチル t−ブチルエーテル(MTBE)、メチルテトラヒドロフラン(MeTHF)、N−ブロモスクシンイミド(NBS)、n−ブチルリチウム(nBuLi)、N−カルボキシアンヒドリド(NCA)、N−クロロスクシンイミド(NCS)、N−メチルモルホリン(NMM)、N−メチルピロリドン(NMP)クロロクロム酸ピリジニウム(PCC)、ジクロロ−((ビス−ジフェニルホスフィノ)フェロセニル)パラジウム(II)(Pd(dppf)Cl2)、酢酸パラジウム(II)(Pd(OAc)2)、トリス(ジベンジリデンアセトン)二パラジウム(0)(Pd2(dba)3)、二クロム酸ピリジニウム(PDC)、フェニル(Ph)、プロピル(Pr)、イソ−プロピル(i−Pr)、ポンド/平方インチ(psi)、ピリジン(pyr)、1,2,3,4,5−ペンタフェニル−1’−(ジ−tert−ブチルホスフィノ)フェロセン(Q−Phos)、室温(周囲温度、rtまたはRT)、sec−ブチルリチウム(sBuLi)、tert−ブチルジメチルシリルまたはt−BuMe2Si(TBDMS)、テトラ−n−ブチルアンモニウムフルオリド(TBAF)、トリエチルアミン(TEAまたはEt3N)、2,2,6,6−テトラメチルピペリジン 1−オキシル(TEMPO)、トリフレートまたはCF3SO2−(Tf)、トリフルオロ酢酸(TFA)、1,1’−ビス−2,2,6,6−テトラメチルヘプタン−2,6−ジオン(TMHD)、O−ベンゾトリアゾール−1−イル−N,N,N’,N’−テトラメチルウロニウムテトラフルオロボレート(TBTU)、薄層クロマトグラフィー(TLC)、テトラヒドロフラン(THF)、トリメチルシリルまたはMe3Si(TMS)、p−トルエンスルホン酸 1水和物(TsOHまたはpTsOH)、4−Me−C6H4SO2−またはトシル(Ts)、およびN−ウレタン−N−カルボキシアンヒドリド(UNCA)。接頭辞ノルマル(n)、イソ(i−)、第二級(sec−)、第三級(tert−)およネオを含む一般的名称は、アルキル部分と一緒に用いられる場合、それらの一般的な意味をもつ。(J. Rigaudy and D. P. Klesney, Nomenclature in Organic Chemistry, IUPAC 1979 Pergamon Press, Oxford.)。
[0126] 本発明の化合物は以下の実施例のセクションに記載する具体的な合成反応に示す多様な方法により製造できる。
実施例1
N*3*−(4−ブロモ−3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物1)
1H NMR (300MHz, DMSO) δ: 11.35 (s, 1H), 9.33 (s, 1H), 7.75 (s, 2H), 6.05 (s, 2H) ppm。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−ベンゾニトリル(化合物2)
1H NMR (300MHz, DMSO) δ: 11.55 (s, 1H), 9.99 (s, 1H), 7.74 (s, 2H), 6.14 (s, 2H) ppm。
N*3*−(3,5−ジクロロ−4−ヨード−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物3)
1H NMR (300MHz, DMSO) δ: 11.30 (s, 1H), 9.23 (s, 1H), 7.71 (s, 2H), 5.98 (s, 2H) ppm。
N*3*−(3−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物4)
1H NMR (300MHz, DMSO) δ: 11.41 (s, 1H), 9.49 (s, 1H), 8.48 (m, 1H), 7.90 (dd, J=9Hz, 2Hz, 1H ), 7.62 (t, J=8 Hz ,1H), 7.44-7.41 (m, 1H), 6.04 (s, 2H) ppm。
N*3*−(4−ブロモ−3−クロロ−5−フルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物5,中間体5)
MS m/z 306, 308 [M+H]。
N*3*−(3−tert−ブチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物6)
1H NMR (300MHz, DMSO) δ: 11.10 (s, 1H), 8.45 (s, 1H), 7.52 (s, 1H), 7.33 (dd, J =8 Hz,1 Hz, 1H ), 7.06 (t, J=8 Hz ,1H), 6.76-6.73 (m, 1H), 5.83 (s, 2H), 1.25 (s 9H) ppm。
N*3*−(3−クロロ−4−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物7)
1H NMR (300MHz, DMSO) δ : 11.43 (s, 1H), 9.71 (s, 1H), 7.94 (d, J=2 Hz, 1H), 7.73-7.61 (m, 2H), 6.03 (s, 2H) ppm。
N*3*−(3−クロロ−4−ニトロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物8)
1H NMR (300MHz, DMSO) δ: 11.53 (s, 1H), 9.92 (s, 1H), 8.07 (d, J =9 Hz, 1H), 7.93 (d, J=2 Hz ,1H), 7.45 (dd, J=9 Hz, 3 Hz, 1H), 6.12 (s, 2H) ppm。
N*3*−(3−クロロ−4−エチニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物9)
(2−クロロ−4−イソチオシアナトフェニル)エチニル)トリメチルシラン
MS m/z 234 [M+H]。
N*3*−(3−クロロ−4−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物10)
N*3*−(3,4,5−トリクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物11)
MS m/z 278, 280 [M+H]。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−ベンゾニトリル(化合物12)
MS m/z 235 [M+H]。
N*3*−(4−クロロ−3−ニトロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物13)
1H NMR (300MHz, DMSO) δ: 11.38 (s, 1H), 9.46 (s, 1H), 8.34 (d, J=3 Hz, 1H), 7.64-7.60 (m, 2H ), 6.04 (s, 2H) ppm。
N*3*−(3−クロロ−4−フェニルエチニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物14)
MS m/z 310 [M+H]。
N*3*−(3−ブロモ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物15)
MS m/z 254, 256 [M+H]。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−tert−ブチル−ベンゾニトリル(化合物16)
1H NMR (300MHz, DMSO) δ: 11.21 (s, 1H), 8.98 (s, 1H), 8.01 (d, J=2 Hz, 1H), 7.55 (dd, J=9 Hz,3 Hz, 1H ), 7.33 (d, J=9 Hz ,1H), 5.93 (s, 2H), 1.40 (s, 9H) ppm。
N*3*−(4−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物17)
N*3*−ナフタレン−2−イル−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物18)
1H NMR (300MHz, DMSO) δ 11.17 (s, 1H), 8.85 (s, 1H), 8.11 (s, 1H), 7.70-7.65 (m, 2H), 7.60 (d, J=8 Hz, 1H), 7.47 (dd, J=9 Hz, 2 Hz, 1H), 7.36 (m, 1H), 7.21 (m, 1H), 5.87 (s, 2H) ppm。
N*3*−(3,5−ジ−tert−ブチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物19)
1H NMR (300MHz, DMSO) δ 11.04 (s, 1H), 8.25 (s, 1H), 7.38 (d, J=1 Hz, 2H), 5.76 (s, 2H), 1.24 (s, 18H) ppm。
N*3*−(4−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物20)
1H NMR (300MHz, DMSO) δ 11.36 (s, 1H), 9.40 (s, 1H), 7.67 (m, 4H), 6.00 (s, 2H), 3.09 (s, 3H) ppm。
N*3*−(3−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物21)
1H NMR (300MHz, DMSO) δ: 11.29 (s, 1H), 9.17 (s, 1H), 8.18 (m, 1H), 7.71 (m, 1H), 7.43 (t, J=8 Hz, 1H), 7.24 (m, 1H), 5.96 (s, 2H), 3.13 (s, 3H) ppm。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N−メチル−ベンゼンスルホンアミド(化合物22)
1H NMR (300MHz, DMSO) δ: 11.33 (s, 1H), 9.27 (s, 1H), 7.58 (dd, J=20 Hz, 11 Hz, 4H), 7.08 (q, J=5 Hz, 1H), 5.97 (s, 2H), 2.50 (d, J= 2 Hz, 3H) ppm。
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−モルホリン−4−イル−メタノン(化合物23)
1H NMR (300MHz, DMSO) δ: 11.23 (s, 1H), 8.96 (s, 1H), 7.39 (dd, J=80 Hz, 9 Hz, 4H), 5.91 (s, 2H), 3.58-3.49 (m, 8H) ppm。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N,N−ジメチル−ベンズアミド(化合物24)
1H NMR (300MHz, DMSO) δ: 11.22 (s, 1H), 8.93 (s, 1H), 7.38 (dd, J=75 Hz, 8 Hz, 4H), 5.91 (s, 2H), 2.95 (s, 6H) ppm。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−ベンゼンスルホンアミド(化合物25)
1H NMR (300MHz, DMSO) δ : 11.32 (s, 1H), 9.21 (s, 1H), 7.61 (m, 4H), 7.04 (bs, 1H), 5.95 (s, 2H) ppm。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N,N−ジメチル−ベンゼンスルホンアミド(化合物26)
1H NMR (300MHz, DMSO) δ: 11.31 (s, 1H), 9.31 (s, 1H), 7.59 (dd, J=41 Hz, 9 Hz, 4H), 5.92 (s, 2H), 2.53 (s, 6H) ppm。
N*3*−メチル−N*3*−(3,4,5−トリクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物27)
N*3*−(3,5−ジクロロ−フェニル)−N*3*−メチル−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物28)
MS m/z 258, 260 [M+H]。
N*3*−ベンジル−N*3*−(3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物29)
MS m/z 334, 336 [M+H]。
[(5−アミノ−1H−[1,2,4]トリアゾール−3−イル)−(3,5−ジクロロ−フェニル)−アミノ]−アセトニトリル(化合物30)
MS m/z 283, 285 [M+H]。
3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−安息香酸(化合物31)
MS m/z 220 [M+H]。
N*3*−[3−tert−ブチルスルファニル−5−(2−メチル−プロパン−2−スルフィニル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物32)
MS m/z 392 [M+H]。
N−[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−メタンスルホンアミド(化合物33)
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−トリフルオロメタンスルホニル−ベンゾニトリル(化合物34)
MS m/z 333 [M+H]。
4−(5−アミノ−1H−1,2,4−トリアゾール−3−イルアミノ)−2−シクロプロピルベンゾニトリル(化合物35)
N*3*−(3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物36)
N*3*−(4−ベンジルオキシ−3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物37)
N*3*−(3,5−ジクロロ−4−メチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物38)
N*3*−(3,5−ジクロロ−4−メチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物39)
N*3*−(4−ブロモ−3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物40)
3−アミノ−5−(3,5−ジクロロアニリノ)−S−トリアゾール(化合物41)
N3−(4−ブロモ−3−クロロ−5−(トリフルオロメチル)フェニル)−1H−1,2,4−トリアゾール−3,5−ジアミン(化合物42)
4−(5−アミノ−1H−1,2,4−トリアゾール−3−イルアミノ)−2−クロロ−6−(トリフルオロメチル)ベンゾニトリル(化合物43)
N3−(3,5−ジクロロ−4−(モルホリノスルホニル)フェニル)−1H−1,2,4−トリアゾール−3,5−ジアミン(化合物44)
N5−(4−ブロモ−3−フルオロ−5−トリフルオロメチルフェニル)−1H−[1,2,4]−トリアゾール−3,5−ジアミン(化合物45,中間体3)
1H NMR (300 MHz, DMSO-d6) δ ppm 7.84 (s, 1 H) 7.96 (dd, J=9.06, 2.27 Hz, 1 H)。
1H NMR (300 MHz, DMSO-d6) δ ppm 2.78 (s, 3 H) 7.87 (s, 1 H) 7.97 (dd, J=1.00 Hz, 1 H) 10.38 (br. s, 1 H)。
1H NMR (400 MHz, DMSO-d6) δ ppm 6.03 (s, 2 H) 7.81 (s, 1 H) 7.86 (d, J=12.13 Hz, 1 H) 9.52 (s, 1 H) 11.40 (s, 1 H)。
N*5*−(4−ブロモ−3,5−ジフルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物46,中間体4)
1H NMR (300 MHz, DMSO-d6) δ ppm 2.74 (s, 3 H) 7.47 (d, J=8.69 Hz, 2 H) 10.35 (s, 1 H)。
1H NMR (300 MHz, DMSO-d6) δ ppm 6.00 (br. s., 2 H) 7.36 (d, J=10.58 Hz, 2 H) 9.37 (s, 1 H) 11.35 (br. s., 1 H)。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−ベンゾニトリル(化合物47)
3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−5−クロロ−ベンゾニトリル(化合物48)
N*3*−(2,3−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物49)
N*3*−(3−クロロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物50)
N*3*−(4−クロロ−3−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物51)
N*3*−(3−トリフルオロメトキシ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物52)
N*3*−(2−フルオロ−3−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物53)
N*3*−(2−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物54)
N*3*−[3−(2,2,2−トリフルオロ−エチル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物55)
N*3*−(3−イソプロピル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物56)
N*3*−(3−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物57)
[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−フェニル−メタノン(化合物58)
1−[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−シクロプロパンカルボニトリル(化合物59)
N*3*−(3−クロロ−4−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物60)
N*3*−(3−クロロ−5−フルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物61)
1−[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−フェニル]−3−メチル−尿素(化合物62)
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−安息香酸メチルエステル(化合物63)
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−N−フェニル−ベンズアミド(化合物64)
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−フェニル]−ピロリジン−1−イル−メタノン(化合物65)
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−N−(3−メタンスルホニル−フェニル)−ベンズアミド(化合物66)
N*3*−(3,5−ジクロロ−4−ビニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物67)
N5−(4−シアノ−3−フルオロ−5−トリフルオロメチルフェニル)−1H−[1,2,4]−トリアゾール−3,5−ジアミン(化合物68)
N5−(4−シアノ−3,5−ジフルオロフェニル)−1H−[1,2,4]−トリアゾール−3,5−ジアミン(化合物69)
1H NMR (300 MHz, DMSO-d6) δ ppm 6.11 (s, 2 H) 7.38 (d, J=12.47 Hz, 2 H) 10.07 (br. s., 1 H) 11.57 (br. s., 1 H)。
N*3*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物70)
MS+ m/z: 301.9 (M+H)+。
1−メチル−N*5*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物71)
1−シクロヘキシル−N*5*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物72)
NMR (300 MHz, DMSO d6): 9.20 (1H, s); 8.21 (1H, 幅広いs); 7.64 (1H, 幅広いd, J=8 Hz); 7.37 (1H, 幅広いt, J= 8 Hz); 7.18 (1H, 幅広いd, J= 8 Hz); 6.11 (2H, s); 4.03-3.88 (1H, m); 3.68-3.52 (1H, m); 3.20-3.07 (1H, m); 1.90-1.59 (6H, m); 1.45-1.20 (2H, m).
MS+ m/z: 384.1 (M+H)+。
N*3*−(3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物73)
MS+ m/z: 335.9 (M+H)+。
MS+ m/z: 318.0 (M+H)+。
N*5*−(3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1−メチル−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物74)
NMR (300 MHz, DMSO d6): 9.40 (1H, s); 7.98 (1H, 幅広いd, J= 8 Hz); 7.85 (1H, 幅広いs); 7.32 (1H, 幅広いd, J= 8 Hz); 5.2 (2H, s); 3.52 (3H, s).
MS+ m/z: 334.0 (M+H)+。
N*3*−(4−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物75)
MS+ m/z: 301.9 (M+H)+。
N3−(3−クロロ−4−メチルフェニル)−1H−1,2,4−トリアゾール−3,5−ジアミン(化合物76)
N3−(3−クロロ−4−(メチルスルホニル)フェニル)−1H−1,2,4−トリアゾール−3,5−ジアミン(化合物77)
MS+ m/z: 287.9 (M+H)+。
4−(5−アミノ−1H−1,2,4−トリアゾール−3−イルアミノ)−2−クロロ−N,N−ジメチルベンズアミド(化合物78)
N3−(3,5−ジクロロ−4−(3,3−ジメチルブタ−1−イニル)フェニル)−1H−1,2,4−トリアゾール−3,5−ジアミン(化合物79)
MS+ m/z: 326.0 (M+H)+。
N3−(3−クロロ−4−(3,3−ジメチルブタ−1−イニル)フェニル)−1H−1,2,4−トリアゾール−3,5−ジアミン(化合物80)
MS+ m/z: 290.0 (M+H)+。
N*3*−(4−ブロモ−3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物81)
MS+ m/z: 380.0 (M+H)+。
N*3*−(3−ブロモ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物82)
MS+ m/z: 380.0 (M+H)+。
N*3*−(4−ブロモ−3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン(化合物83)
MS+ m/z: 400.0 (M+H)+。
2−(4−(5−アミノ−1H−1,2,4−トリアゾール−3−イルアミノ)−2−クロロ−6−(トリフルオロメチル)フェニル)アセトニトリル(化合物84)
NMR (300 MHz, DMSO d6): 11.40 (1H, s); 9.50 (1H, s); 8.06 (1H, s); 7.91 (1H, s); 6.06 (2H,); 3.96 (2H,s)。
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−ペンタフルオロ硫黄−ベンゾニトリル(化合物85)
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−フルオロ−6−ペンタフルオロ硫黄−ベンゾニトリル(化合物86)および
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−ヒドラジノ−6−ペンタフルオロ硫黄−ベンゾニトリル(化合物87)
画分1(実施例26):60mg(85%)を黄色固体として得た。MS+ m/z: 345.0 (M+H)+。
画分2(実施例27):15mg(21%)を黄色固体として得た。MS+ m/z: 357.0 (M+H)+。
(1−アセチル−5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−ベンゾニトリル(化合物88)
MS(H+)=310.85。
4−[5−アミノ−1−(4−トリフルオロメチル−ベンゼンスルホニル)−1H−[1,2,4]トリアゾール−3−イルアミノ]−2,6−ジクロロ−ベンゾニトリル(化合物89)
N3−(4−((1H−テトラゾール−5−イル)メチル)−3−クロロ−5−(トリフルオロメチル)フェニル)−1H−1,2,4−トリアゾール−3,5−ジアミン(化合物90)
MS+ m/z: 360.0 (M+H)+。
[0413] シュードドタイプ(pseudotyped)HCV粒子(HCVpp)レポーターアッセイを用いる、化合物のHCV GT1bおよびGT1a侵入阻害活性の判定。
[0414] GT1a H77株(Proc Natl Acad Sci USA 1997 94:8738-43)またはGT1b Con1株(Science 1999 285:110-3)のHCV E1およびE2エンベロープタンパク質を発現するプラスミドは、HCVコアタンパク質の最後の60個のアミノ酸ならびにHCV E1およびE2タンパク質のすべてをコードする核酸をpcDNA3.1(+)ベクター内へクローニングすることにより構築された。水疱性口内炎ウイルス(VSV G)の糖タンパク質Gを発現するプラスミドpVSV−Gは、Clontechからのものである(カタログ# 631530)。ホタルルシフェラーゼレポーター遺伝子を発現するHIVパッケージング構築体は、エンベロープ欠損pNL.4.3.Luc−R−.E−ベクター(Virology 1995 206:935-44)を基礎とし、HIVエンベロープタンパク質の一部をさらに欠失させることにより修飾された。
[0415] シュードドタイプHCV GT1aおよびGT1b粒子(HCVpp)ならびにシュードドタイプVSV G粒子(VSVpp)を、一過性トランスフェクションしたHEK−293T細胞(ATCC カタログ# CRL−573)から作製した。HCVppを作製するために、HEK−293T細胞に、等量のHCVエンベロープタンパク質発現プラスミドおよびHIVパッケージングゲノム発現プラスミドを、トランスフェクション試薬としてのポリエチレンイミン(Polysciences カタログ# 23966)の使用によりトランスフェクションした。VSVppを作製するために、HEK−293T細胞に、等量のVSV G発現プラスミドおよびHIVパッケージングゲノム発現プラスミドを、ポリエチレンイミンの使用によりトランスフェクションした。トランスフェクションの24時間後、トランスフェクション混合物を含有する細胞培養培地を、10%のウシ胎仔血清(Invitrogen カタログ# 10082−147)および2mMのL−グルタミン(Invitrogen カタログ# 25030−081)を補充した新鮮なダルベッコの改良イーグル培地(DMEM−Glutamax(商標)−I;Invitrogen カタログ# 10569−010)で交換した。トランスフェクションの48時間後に上清を採集し、無菌0.45μmフィルターにより濾過した。上清のアリコートを凍結し、使用するまで−80℃に保存した。
[0417] Huh7−高CD81細胞を細胞密度8000個/ウェルで96ウェルプレート(Perkin Elmer,カタログ# 6005660)に播種した。10%のウシ胎仔血清(Invitrogen カタログ# 10082−147)および1%のペニシリン/ストレプトマイシン(Invitrogen カタログ# 15070−063)を補充したダルベッコの改良イーグル培地(DMEM−Glutamax(商標)−I;Invitrogen カタログ# 10569−010)100μl中において、細胞を播種した。細胞を37℃および5% CO2で24時間、平衡化し、その時点で化合物およびシュードタイプウイルス粒子を添加した。アッセイ当日、HCVppのアリコートを37℃の水浴中で融解し、使用時まで4℃で保持した。化合物(または対照としての培地)を、3倍希釈系列で、2%のDMSOおよび2%のペニシリン/ストレプトマイシンを含むDMEM−Glutamax(商標)−I中に希釈した。それぞれの培養ウェル内の100μlの播種用培地を除去し、続いて50μlの化合物希釈液および50μlの融解HCVppを添加した。化合物およびHCVppを添加した72時間後に、Steady−Gloルシフェラーゼアッセイシステム(Promega,カタログ# E2520)を製造業者の指示に従って用いて、ホタルルシフェラーゼレポーター信号を読み取った。化合物の非存在下での対照と比較し、化合物用量応答データの非線形フィッティングにより判定して、ホタルルシフェラーゼレポーターのレベルの50%低下がみられた化合物濃度として、EC50値を定めた。
[0418] Huh7 hCD81細胞アッセイプレートおよび化合物希釈液を、HCVppアッセイの場合と同じ様式でセットアップした。細胞播種の24時間後に、融解VSVppを、10%のウシ胎仔血清を補充したDMEM−Glutamax(商標)−Iにより800倍希釈した。細胞播種用の培地を培養ウェルから除去した後、50μlの化合物希釈液および50μlの希釈HCVppをウェルに添加した。化合物およびHCVppを添加した72時間後に、Steady−Gloルシフェラーゼアッセイシステム(Promega,カタログ# E2520)を用いて、ホタルルシフェラーゼレポーター信号を読み取った。化合物の非存在下での対照と比較し、化合物用量応答データの非線形フィッティングにより判定して、ホタルルシフェラーゼレポーターのレベルの50%低下がみられた化合物濃度として、EC50値を定めた。最大阻害率が90%未満および70%より大である場合はEC50を概算した。代表的なアッセイデータを下記の表IIに見ることができる。
Claims (22)
- 式Iの化合物:
R1は、H、ハロ、低級ハロアルキル、低級ハロアルキル低級アルキル、トリフルオロメチルスルホニル、低級アルキル、アルコキシ、ニトロ、カルボキシル、低級アルキルスルホンアミド、トリフルオロメチルスルフィニル、シクロアルキル、SF5、または−NHNH2であり;
R2は、H、ハロ、シアノ、ニトロ、トリフルオロメチルスルホニル、低級ハロアルキル、フェニルエチニル、低級アルキルスルホニル、低級アルキルアミノスルホニル、低級アルキルアミド、アミノスルホニル、スルホンアミド、ベンジルオキシ、シクロアルキル、ヘテロシクロアルキルスルホニル、アリールカルボニル、低級アルキルウレア、低級アルキルエステル、フェニルアミド、ヘテロシクロアルキルカルボニル、低級アルキルスルホニルフェニルアミド、低級アルキルシアノ、シアノ低級アルキル、またはテトラゾリル低級アルキルであり;
R3は、H、ハロ、低級アルキル、低級アルケニル、低級ハロアルキル、シアノ、低級ハロアルキルオキシ、シアノシクロアルキル、低級ハロアルキル低級アルキル、SF5、またはトリフルオロメチルスルファニルであり;あるいは
R2とR3は、一緒にアリール環系を形成し;
R4は、H、低級アルキル、シアノ低級アルキル、またはフェニル低級アルキルであり;
R5は、非存在、H、低級アルキル、またはシクロアルキルであり;
R6は、Hまたはハロであり;
R7は、非存在、H、低級アルキルカルボニル、または低級ハロアルキルフェニルスルホニルであり;
ただし、R5が非存在である場合、R7は非存在ではなく;
ただし、R7が非存在である場合、R5は非存在ではない]
またはその医薬的に許容できる塩。 - R5がHである、請求項1に記載の化合物。
- R4がHである、請求項2に記載の化合物。
- R6がHである、請求項3に記載の化合物。
- R1がハロである、請求項1〜4のいずれか1項に記載の化合物。
- R2がハロである、請求項1〜5のいずれか1項に記載の化合物。
- R3がハロである、請求項1〜6のいずれか1項に記載の化合物。
- R3が低級ハロアルキルである、請求項1〜6のいずれか1項に記載の化合物。
- R1がHである、請求項1〜3のいずれか1項に記載の化合物。
- R2がHである、請求項1〜3のいずれか1項に記載の化合物。
- R3がHである、請求項1〜3のいずれか1項に記載の化合物。
- 下記からなる群から選択される化合物:
N3−(4−ブロモ−3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−ベンゾニトリル;
N3−(3,5−ジクロロ−4−ヨード−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−ブロモ−3−クロロ−5−フルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−tert−ブチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−ニトロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−エチニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,4,5−トリクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−ベンゾニトリル;
N3−(4−クロロ−3−ニトロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−フェニルエチニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−ブロモ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−tert−ブチル−ベンゾニトリル;
N3−(4−トリフルオロメタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−ナフタレン−2−イル−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジ−tert−ブチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N−メチル−ベンゼンスルホンアミド;
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−モルホリン−4−イル−メタノン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N,N−ジメチル−ベンズアミド;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−ベンゼンスルホンアミド;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−N,N−ジメチル−ベンゼンスルホンアミド;
N3−メチル−N3−(3,4,5−トリクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジクロロ−フェニル)−N3−メチル−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−ベンジル−N3−(3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
[(5−アミノ−1H−[1,2,4]トリアゾール−3−イル)−(3,5−ジクロロ−フェニル)−アミノ]−アセトニトリル;
3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−安息香酸;
N3−(3−トリフルオロメタンスルフィニル−5−トリフルオロメチルスルファニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N−[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−メタンスルホンアミド;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−トリフルオロメタンスルホニル−ベンゾニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−シクロプロピル−ベンゾニトリル;
N3−(3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−ベンジルオキシ−3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジクロロ−4−メチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン
N3−(3,5−ジクロロ−4−シクロプロピル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン
N3−(4−ブロモ−3−クロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3,5−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−ブロモ−3−クロロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−6−トリフルオロメチル−ベンゾニトリル;
N3−[3,5−ジクロロ−4−(モルホリン−4−スルホニル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N5−(4−ブロモ−3−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N5−(4−ブロモ−3,5−ジフルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−ベンゾニトリル;
3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−5−クロロ−ベンゾニトリル;
N3−(2,3−ジクロロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(4−クロロ−3−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−トリフルオロメトキシ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(2−フルオロ−3−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(2−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−[3−(2,2,2−トリフルオロ−エチル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−イソプロピル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−フェニル−メタノン;
1−[3−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−フェニル]−シクロプロパンカルボニトリル;
N3−(3−クロロ−4−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−5−フルオロ−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
1−[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−フェニル]−3−メチル−尿素;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−安息香酸 メチルエステル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−N−フェニル−ベンズアミド;
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−フェニル]−ピロリジン−1−イル−メタノン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−N−(3−メタンスルホニル−フェニル)−ベンズアミド;
N3−(3,5−ジクロロ−4−ビニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−2H−[1,2,4]トリアゾール−3−イルアミノ)−2−フルオロ−6−トリフルオロメチル−ベンゾニトリル;
N3−(3−フルオロ−5−トリフルオロメチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−2H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジフルオロ−ベンゾニトリル;
N*3*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
1−メチル−N*5*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
シクロヘキシル−N*5*−(3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*5*−(3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1−メチル−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(4−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−メチル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−(3−クロロ−4−メタンスルホニル−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−N,N−ジメチル−ベンズアミド;
N3−[3,5−ジクロロ−4−(3,3−ジメチル−ブタ−1−イニル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N3−[3−クロロ−4−(3,3−ジメチル−ブタ−1−イニル)−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(4−ブロモ−3−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(3−ブロモ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
N*3*−(4−ブロモ−3−フルオロ−5−ペンタフルオロ硫黄−フェニル)−1H−[1,2,4]トリアゾール−3,5−ジアミン;
[4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−クロロ−6−トリフルオロメチル−フェニル]−アセトニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−ペンタフルオロ硫黄−ベンゾニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−フルオロ−6−ペンタフルオロ硫黄−ベンゾニトリル;
4−(5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2−ヒドラジノ−6−ペンタフルオロ硫黄−ベンゾニトリル;
4−(1−アセチル−5−アミノ−1H−[1,2,4]トリアゾール−3−イルアミノ)−2,6−ジクロロ−ベンゾニトリル;
4−[5−アミノ−1−(4−トリフルオロメチル−ベンゼンスルホニル)−1H−[1,2,4]トリアゾール−3−イルアミノ]−2,6−ジクロロ−ベンゾニトリル;および
N3−[3−クロロ−4−(1H−テトラゾール−5−イルメチル)−5−トリフルオロメチル−フェニル]−1H−[1,2,4]トリアゾール−3,5−ジアミン。 - C型肝炎ウイルス(HCV)感染症を予防するための方法であって、その必要がある患者に療法有効量の請求項1〜12のいずれか1項に記載の化合物を投与することを含む方法。
- さらに、その必要がある患者に療法有効量の免疫系抑制剤を投与することを含む、請求項13に記載の方法。
- C型肝炎ウイルス(HCV)感染症を治療するための方法であって、その必要がある患者に療法有効量の請求項1〜12のいずれか1項に記載の化合物を投与することを含む方法。
- さらに、HCVの複製を阻害する抗ウイルス剤の組合わせを投与することを含む、請求項13〜15のいずれか1項に記載の方法。
- さらに、免疫系調節剤もしくはHCVの複製を阻害する抗ウイルス剤、またはその組合わせを投与することを含む、請求項13〜16のいずれか1項に記載の方法。
- 免疫系抑制剤がインターフェロンまたは化学的に誘導体化したインターフェロンである、請求項17に記載の方法。
- 抗ウイルス剤が、HCVプロテアーゼ阻害剤、HCVポリメラーゼ阻害剤、HCVヘリカーゼ阻害剤、HCV NS5A阻害剤、またはそのいずれかの組合わせからなる群から選択される、請求項17に記載の方法。
- 請求項1〜12のいずれか1項に記載の化合物および医薬的に許容できる賦形剤を含む組成物。
- 療法有効物質として使用するための、請求項1〜12のいずれか1項に記載の化合物。
- C型肝炎ウイルス(HCV)感染症の治療または予防のための、請求項1〜12のいずれか1項に記載の化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261668547P | 2012-07-06 | 2012-07-06 | |
US61/668,547 | 2012-07-06 | ||
PCT/EP2013/063980 WO2014006066A1 (en) | 2012-07-06 | 2013-07-03 | Triazole compounds as antivirals |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015525743A true JP2015525743A (ja) | 2015-09-07 |
JP6039067B2 JP6039067B2 (ja) | 2016-12-07 |
Family
ID=48793192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015519200A Expired - Fee Related JP6039067B2 (ja) | 2012-07-06 | 2013-07-03 | 抗ウイルス剤としてのトリアゾール化合物 |
Country Status (11)
Country | Link |
---|---|
US (2) | US20140010783A1 (ja) |
EP (1) | EP2870143B1 (ja) |
JP (1) | JP6039067B2 (ja) |
KR (1) | KR20150029016A (ja) |
CN (1) | CN104428289B (ja) |
BR (1) | BR112015000011A2 (ja) |
CA (1) | CA2873512A1 (ja) |
HK (1) | HK1208455A1 (ja) |
MX (1) | MX2014015884A (ja) |
RU (1) | RU2015102610A (ja) |
WO (1) | WO2014006066A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016505056A (ja) * | 2013-01-23 | 2016-02-18 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 抗ウイルス性トリアゾール誘導体 |
JP2016510050A (ja) * | 2013-03-05 | 2016-04-04 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 抗ウイルス性化合物 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2015011126A (es) | 2013-03-05 | 2015-11-11 | Hoffmann La Roche | Compuestos antivirales. |
CN105008350B (zh) * | 2013-03-05 | 2018-05-08 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒化合物 |
KR20150112035A (ko) * | 2013-03-05 | 2015-10-06 | 에프. 호프만-라 로슈 아게 | Hcv-항바이러스제로서의 n-헤테로아릴 치환된 아닐린 유도체 |
CA2898107A1 (en) | 2013-03-06 | 2014-09-12 | F. Hoffmann-La Roche Ag | Antiviral compounds |
CN106432031A (zh) * | 2016-09-09 | 2017-02-22 | 中国药科大学 | 苯甲酸三氮唑类抗流感病毒化合物及其制备方法和用途 |
CN109422664B (zh) * | 2017-08-23 | 2022-02-18 | 中国科学院福建物质结构研究所 | 一类干扰素调节剂及其制备方法和用途 |
WO2023076219A2 (en) * | 2021-10-26 | 2023-05-04 | Vasocardea, Inc. | Antagonists of gpr39 protein |
WO2023128786A1 (en) * | 2021-12-30 | 2023-07-06 | Collaborations Pharmaceuticals, Inc | New antiviral triazole derivatives, their synthesis and their use for treatment of mammalian viral infections |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002057240A1 (en) * | 2000-12-22 | 2002-07-25 | Ortho Mc Neil Pharmaceutical, Inc. | Substituted triazole diamine derivatives as kinase inhibitors |
JP2003506362A (ja) * | 1999-08-02 | 2003-02-18 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Gsk−3阻害剤としてのジアミノ−1,2,4−トリアゾール−カルボン酸誘導体 |
WO2004032875A2 (en) * | 2002-10-11 | 2004-04-22 | Bristol-Myers Squibb Company | Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents |
JP2004532248A (ja) * | 2001-05-08 | 2004-10-21 | シエーリング アクチエンゲゼルシャフト | キナーゼ阻害物質としての3,5−ジアミノ−1,2,4,−トリアゾール |
JP2006515313A (ja) * | 2002-11-15 | 2006-05-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なジアミノトリアゾール |
JP2006528617A (ja) * | 2003-07-24 | 2006-12-21 | ファーマジーン ラボラトリーズ リミテッド | 5−ht2b受容体アンタゴニスト |
JP2007522213A (ja) * | 2004-02-11 | 2007-08-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 置換されたトリアゾール化合物の製造方法 |
WO2007118149A2 (en) * | 2006-04-07 | 2007-10-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical Lollege | Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers |
JP2009507080A (ja) * | 2005-09-07 | 2009-02-19 | リゲル ファーマシューティカルズ,インコーポレーテッド | Axl阻害剤として有用なトリアゾール誘導体 |
WO2011086099A1 (en) * | 2010-01-15 | 2011-07-21 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Novel substituted triazole derivatives as gamma secretase modulators |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
ATE212978T1 (de) * | 1996-03-29 | 2002-02-15 | Searle & Co | Para-substituierte phenylpropansäure derivate als integrin-antagonisten |
CZ298463B6 (cs) | 1996-04-23 | 2007-10-10 | Vertex Pharmaceuticals Incorporated | Deriváty mocoviny pro použití jako inhibitory IMPDH enzymu a farmaceutické prostredky, které je obsahují |
SE508697C2 (sv) | 1996-07-19 | 1998-10-26 | Ericsson Telefon Ab L M | Förfarande och anordning för tidskontinuerlig filtrering i digital CMOS-process |
PL194025B1 (pl) | 1996-10-18 | 2007-04-30 | Vertex Pharma | Inhibitory proteaz serynowych, a zwłaszcza proteazy wirusa NS3 zapalenia wątroby C, kompozycja farmaceutyczna i zastosowanie inhibitorów proteaz serynowych |
GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
US6010848A (en) | 1997-07-02 | 2000-01-04 | Smithkline Beecham Corporation | Screening methods using an atpase protein from hepatitis C virus |
ES2234144T3 (es) | 1997-08-11 | 2005-06-16 | Boehringer Ingelheim (Canada) Ltd. | Analogos de peptidos inhibidores de la hepatitis c. |
WO2000006529A1 (en) | 1998-07-27 | 2000-02-10 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti S.P.A. | Diketoacid-derivatives as inhibitors of polymerases |
US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
AU743411B2 (en) | 1998-08-21 | 2002-01-24 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
CA2343522A1 (en) | 1998-09-04 | 2000-03-16 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
BR9913935A (pt) | 1998-09-25 | 2001-06-19 | Viropharma Inc | Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo |
ES2405316T3 (es) | 1999-03-19 | 2013-05-30 | Vertex Pharmaceuticals Incorporated | Inhibidores de la enzima IMPDH |
WO2001032153A2 (en) | 1999-11-04 | 2001-05-10 | Shire Biochem Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
US6518253B1 (en) * | 1999-11-19 | 2003-02-11 | Robert Tam | Treatment of viral infections using the L-isomer of ribavirin |
US20040034041A1 (en) | 2000-05-10 | 2004-02-19 | Dashyant Dhanak | Novel anti-infectives |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
EP1395571A1 (en) | 2001-06-11 | 2004-03-10 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
AP1753A (en) | 2001-06-11 | 2007-07-18 | Shire Biochem Inc | Thiophene derivatives as antiviral agents for flavvivirus infection |
AR035543A1 (es) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
WO2003007945A1 (en) | 2001-07-20 | 2003-01-30 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
US20050043545A1 (en) | 2001-11-02 | 2005-02-24 | Gianpalol Bravi | 4-(5-Membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
US7259163B2 (en) | 2001-11-02 | 2007-08-21 | Glaxo Group Limited | 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as HCV inhibitors |
US20050009873A1 (en) | 2001-11-02 | 2005-01-13 | Gianpaolo Bravi | Acyl dihydro pyrrole derivatives as hcv inhibitors |
CN1738615A (zh) * | 2002-11-15 | 2006-02-22 | 沃泰克斯药物股份有限公司 | 用作蛋白质激酶的抑制剂的二氨基三唑类 |
ES2336009T3 (es) | 2004-01-30 | 2010-04-07 | Medivir Ab | Inhibidores de la ns-3 serina proteasa del vhc. |
US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2009003077A1 (en) | 2007-06-27 | 2008-12-31 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
WO2010108187A2 (en) * | 2009-03-20 | 2010-09-23 | Brandeis University | Compounds and methods for treating mammalian gastrointestinal microbial infections |
WO2013103384A1 (en) * | 2012-01-06 | 2013-07-11 | Elcelyx Therapeutics, Inc. | Biguanide compositions and methods of treating metabolic disorders |
MX2014014106A (es) * | 2012-05-23 | 2015-09-25 | Savira Pharmaceuticals Gmbh | Derivados de acido 7-oxo-tiazolopiridinocarbonico y su uso en el tratamiento, disminucion o prevencion de una enfermedad viral. |
-
2013
- 2013-07-02 US US13/933,468 patent/US20140010783A1/en not_active Abandoned
- 2013-07-03 BR BR112015000011A patent/BR112015000011A2/pt not_active IP Right Cessation
- 2013-07-03 CA CA2873512A patent/CA2873512A1/en not_active Abandoned
- 2013-07-03 MX MX2014015884A patent/MX2014015884A/es unknown
- 2013-07-03 KR KR1020157003023A patent/KR20150029016A/ko active IP Right Grant
- 2013-07-03 EP EP13737175.3A patent/EP2870143B1/en not_active Not-in-force
- 2013-07-03 CN CN201380035774.1A patent/CN104428289B/zh not_active Expired - Fee Related
- 2013-07-03 RU RU2015102610A patent/RU2015102610A/ru not_active Application Discontinuation
- 2013-07-03 JP JP2015519200A patent/JP6039067B2/ja not_active Expired - Fee Related
- 2013-07-03 WO PCT/EP2013/063980 patent/WO2014006066A1/en active Application Filing
-
2015
- 2015-07-07 US US14/792,722 patent/US20150307461A1/en not_active Abandoned
- 2015-09-17 HK HK15109115.4A patent/HK1208455A1/xx not_active IP Right Cessation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003506362A (ja) * | 1999-08-02 | 2003-02-18 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Gsk−3阻害剤としてのジアミノ−1,2,4−トリアゾール−カルボン酸誘導体 |
WO2002057240A1 (en) * | 2000-12-22 | 2002-07-25 | Ortho Mc Neil Pharmaceutical, Inc. | Substituted triazole diamine derivatives as kinase inhibitors |
JP2004532248A (ja) * | 2001-05-08 | 2004-10-21 | シエーリング アクチエンゲゼルシャフト | キナーゼ阻害物質としての3,5−ジアミノ−1,2,4,−トリアゾール |
WO2004032875A2 (en) * | 2002-10-11 | 2004-04-22 | Bristol-Myers Squibb Company | Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents |
JP2006515313A (ja) * | 2002-11-15 | 2006-05-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なジアミノトリアゾール |
JP2006528617A (ja) * | 2003-07-24 | 2006-12-21 | ファーマジーン ラボラトリーズ リミテッド | 5−ht2b受容体アンタゴニスト |
JP2007522213A (ja) * | 2004-02-11 | 2007-08-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 置換されたトリアゾール化合物の製造方法 |
JP2009507080A (ja) * | 2005-09-07 | 2009-02-19 | リゲル ファーマシューティカルズ,インコーポレーテッド | Axl阻害剤として有用なトリアゾール誘導体 |
WO2007118149A2 (en) * | 2006-04-07 | 2007-10-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical Lollege | Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers |
WO2011086099A1 (en) * | 2010-01-15 | 2011-07-21 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Novel substituted triazole derivatives as gamma secretase modulators |
Non-Patent Citations (12)
Title |
---|
JPN5015007629; LIN RONGHUI: '1-ACYL-1H-[1,2,4] TRIAZOLE-3,5- DIAMINE ANALOGUES AS NOVEL AND POTENT ANTICANCER 以下備考' JOURNAL OF MEDICINAL CHEMISTRY V48 N13, 20050603, P4208-4211, AMERICAN CHEMICAL SOCIETY * |
JPN5015007630; MALERICH JEREMIAH P: 'DIAMINO-1,2,4- TRIAZOLE DERIVATIVES ARE SELECTIVE INHIBITORS OF TYK2 AND JAK1 OVER JAK2 AND JAK3' BIOORGANIC & MEDICINAL CHEMISTRY LETTERS V20 N24, 20101215, P7454-7457, PERGAMON * |
JPN5015007631; BLANK BENJAMIN: 'SYNTHESIS OF 1,2,4- TRIAZOLES AS POTENTIAL HYPOGLYCEMIC AGENTS' JOURNAL OF MEDICINAL CHEMISTRY V15 N6, 19720101, P694-696, AMERICAN CHEMICAL SOCIETY * |
JPN5015007632; FROMM EMIL: 'SPALTUNG DER DISULFIDE. SYNTHESE VON TRIAZOLEN' JUSTUS LIEBIGS ANNALEN DER CHEMIE V437 N2, 19240101, P106-124, VERLAG CHEMIE GMBH * |
JPN5015007633; SCOTT J POLLACK: 'A COMPARATIVE STUDY OF FRAGMENT SCREENING METHODS ON THE P38alpha KINASE: NEW METHODS, NEW INSIGHTS' JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN V25 N7, 20110706, P677-687, KLUWER ACADEMIC PUBLISHERS * |
JPN5015007634; DAVIDSON JOHN S.: 'THE ACTION OF HYDRAZINE HYDRATE ON ISODITHIOBIURETS' JOURNAL OF THE CHEMICAL SOCIETY V22, 19670101, P2471-2472, CHEMICAL SOCIETY * |
JPN5015007635; GLASS D: '4-(4-GUANIDINOBENZOYL)-2-IMIDAZOLONES AND RELATED COMPOUNDS: 以下備考' ARCHIV DER PHARMAZIE V328 N10, 19950101, P709-719, WILEY VERLAG * |
JPN6016009647; RAHMAN,A.A. et al: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS Vol.13, 2003, pp.1119-1123 * |
JPN6016009649; DUKAT,M. et al: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS Vol.11, 2001, pp.1599-1603 * |
JPN6016009650; LIU,C. et al: TETRAHEDRON LETTERS Vol.44, 2003, pp.1409-1411 * |
JPN7016000620; RN 281678-95-3 REGISTRY , 20000731 * |
JPN7016000621; RN 24724-64-9 REGISTRY , 19841116 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016505056A (ja) * | 2013-01-23 | 2016-02-18 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 抗ウイルス性トリアゾール誘導体 |
JP2016510050A (ja) * | 2013-03-05 | 2016-04-04 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 抗ウイルス性化合物 |
Also Published As
Publication number | Publication date |
---|---|
BR112015000011A2 (pt) | 2017-06-27 |
US20150307461A1 (en) | 2015-10-29 |
US20140010783A1 (en) | 2014-01-09 |
CN104428289B (zh) | 2017-06-23 |
KR20150029016A (ko) | 2015-03-17 |
MX2014015884A (es) | 2015-03-19 |
CA2873512A1 (en) | 2014-01-09 |
EP2870143B1 (en) | 2017-05-17 |
HK1208455A1 (en) | 2016-03-04 |
WO2014006066A1 (en) | 2014-01-09 |
EP2870143A1 (en) | 2015-05-13 |
CN104428289A (zh) | 2015-03-18 |
RU2015102610A (ru) | 2016-08-27 |
JP6039067B2 (ja) | 2016-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6039067B2 (ja) | 抗ウイルス剤としてのトリアゾール化合物 | |
JP6018715B2 (ja) | 抗ウイルス化合物 | |
JP6163214B2 (ja) | 抗ウイルス化合物 | |
US9511059B2 (en) | Antiviral compounds | |
US9382218B2 (en) | N-heteroaryl substituted aniline derivatives as HCV-antivirals | |
JP2016510050A (ja) | 抗ウイルス性化合物 | |
JP6093456B2 (ja) | 抗ウイルス性化合物 | |
JP6122514B2 (ja) | 抗ウイルス化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160210 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160311 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160606 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161004 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161102 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6039067 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |